The Translational Future of Stress Neurobiology and Psychosis Vulnerability: A Review of the Evidence


Citar

Texto integral

Resumo

Psychosocial stress is a well-established risk factor for psychosis, yet the neurobiological mechanisms underlying this relationship have yet to be fully elucidated. Much of the research in this field has investigated hypothalamic-pituitary-adrenal (HPA) axis function and immuno-inflammatory processes among individuals with established psychotic disorders. However, as such studies are limited in their ability to provide knowledge that can be used to develop preventative interventions, it is important to shift the focus to individuals with increased vulnerability for psychosis (i.e., high-risk groups). In the present article, we provide an overview of the current methods for identifying individuals at high-risk for psychosis and review the psychosocial stressors that have been most consistently associated with psychosis risk. We then describe a network of interacting physiological systems that are hypothesised to mediate the relationship between psychosocial stress and the manifestation of psychotic illness and critically review evidence that abnormalities within these systems characterise highrisk populations. We found that studies of high-risk groups have yielded highly variable findings, likely due to (i) the heterogeneity both within and across high-risk samples, (ii) the diversity of psychosocial stressors implicated in psychosis, and (iii) that most studies examine single markers of isolated neurobiological systems. We propose that to move the field forward, we require well-designed, largescale translational studies that integrate multi-domain, putative stress-related biomarkers to determine their prognostic value in high-risk samples. We advocate that such investigations are highly warranted, given that psychosocial stress is undoubtedly a relevant risk factor for psychotic disorders.

Sobre autores

Alexis Cullen

Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience,, King’s College London

Autor responsável pela correspondência
Email: info@benthamscience.net

Javier Labad

, CIBERSAM,

Email: info@benthamscience.net

Dominic Oliver

Department of Psychiatry, University of Oxford, Warneford Hospital

Email: info@benthamscience.net

Adam Al-Diwani

Department of Psychiatry, University of Oxford, Warneford Hospital

Email: info@benthamscience.net

Amedeo Minichino

Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies,, Institute of Psychiatry, Psychology & Neuroscience, King's College London

Email: info@benthamscience.net

Paolo Fusar-Poli

Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies,, Institute of Psychiatry, Psychology & Neuroscience, King's College London

Email: info@benthamscience.net

Bibliografia

  1. Maj, M.; Os, J.; De Hert, M.; Gaebel, W.; Galderisi, S.; Green, M.F.; Guloksuz, S.; Harvey, P.D.; Jones, P.B.; Malaspina, D.; McGorry, P.; Miettunen, J.; Murray, R.M.; Nuechterlein, K.H.; Peralta, V.; Thornicroft, G.; Winkel, R.; Ventura, J. The clinical characterization of the patient with primary psychosis aimed at personalization of management. World Psychiatry, 2021, 20(1), 4-33. doi: 10.1002/wps.20809 PMID: 33432763
  2. Moreno-Küstner, B.; Martín, C.; Pastor, L. Prevalence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses. PLoS One, 2018, 13(4), e0195687. doi: 10.1371/journal.pone.0195687 PMID: 29649252
  3. Solmi, M.; Radua, J.; Olivola, M.; Croce, E.; Soardo, L.; de Pablo, S.G.; Il, S.J.; Kirkbride, J.B.; Jones, P.; Kim, J.H.; Kim, J.Y.; Carvalho, A.F.; Seeman, M.V.; Correll, C.U.; Fusar-Poli, P. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol. Psychiatry, 2022, 27(1), 281-295. doi: 10.1038/s41380-021-01161-7 PMID: 34079068
  4. Fusar-Poli, P.; McGorry, P.D.; Kane, J.M. Improving outcomes of first-episode psychosis: An overview. World Psychiatry, 2017, 16(3), 251-265. doi: 10.1002/wps.20446 PMID: 28941089
  5. Fusar-Poli, P.; Correll, C.U.; Arango, C.; Berk, M.; Patel, V.; Ioannidis, J.P.A. Preventive psychiatry: A blueprint for improving the mental health of young people. World Psychiatry, 2021, 20(2), 200-221. doi: 10.1002/wps.20869 PMID: 34002494
  6. Rosenthal, D. Genetic theory and abnormal behavior; McGraw-Hill: New York, 1970.
  7. Zubin, J.; Spring, B. Vulnerability: A new view of schizophrenia. J. Abnorm. Psychol., 1977, 86(2), 103-126. doi: 10.1037/0021-843X.86.2.103 PMID: 858828
  8. Walker, E.; Mittal, V.; Tessner, K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu. Rev. Clin. Psychol., 2008, 4(1), 189-216. doi: 10.1146/annurev.clinpsy.4.022007.141248 PMID: 18370616
  9. Walker, E.F.; Diforio, D. Schizophrenia: A neural diathesis-stress model. Psychol. Rev., 1997, 104(4), 667-685. doi: 10.1037/0033-295X.104.4.667 PMID: 9337628
  10. Pruessner, M.; Cullen, A.E.; Aas, M.; Walker, E.F. The neural diathesis-stress model of schizophrenia revisited: An update on recent findings considering illness stage and neurobiological and methodological complexities. Neurosci. Biobehav. Rev., 2017, 73, 191-218. doi: 10.1016/j.neubiorev.2016.12.013 PMID: 27993603
  11. Murray, R.M.; Lewis, S.W. Is schizophrenia a neurodevelopmental disorder? BMJ, 1987, 295(6600), 681-682. doi: 10.1136/bmj.295.6600.681 PMID: 3117295
  12. Howes, O.D.; Murray, R.M. Schizophrenia: An integrated sociodevelopmental-cognitive model. Lancet, 2014, 383(9929), 1677-1687. doi: 10.1016/S0140-6736(13)62036-X PMID: 24315522
  13. Murray, R.M.; Bhavsar, V.; Tripoli, G.; Howes, O. 30 years on: How the neurodevelopmental hypothesis of schizophrenia morphed into the developmental risk factor model of psychosis. Schizophr. Bull., 2017, 43(6), 1190-1196. doi: 10.1093/schbul/sbx121 PMID: 28981842
  14. Howes, O.D.; Kapur, S. The dopamine hypothesis of schizophrenia: Version III--the final common pathway. Schizophr. Bull., 2009, 35(3), 549-562. doi: 10.1093/schbul/sbp006 PMID: 19325164
  15. van Winkel, R.; Stefanis, N.C.; Myin-Germeys, I. Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr. Bull., 2008, 34(6), 1095-1105. doi: 10.1093/schbul/sbn101 PMID: 18718885
  16. Mizrahi, R. Social stress and psychosis risk: Common neurochemical substrates? Neuropsychopharmacology, 2016, 41(3), 666-674. doi: 10.1038/npp.2015.274 PMID: 26346639
  17. Ruby, E.; Polito, S.; McMahon, K.; Gorovitz, M.; Corcoran, C.; Malaspina, D. Pathways associating childhood trauma to the neurobiology of schizophrenia. Front Psychol Behav Sci, 2014, 3(1), 1-17. PMID: 25419548
  18. Vargas, T.; Conley, R.E.; Mittal, V.A. Chronic stress, structural exposures and neurobiological mechanisms: A stimulation, discrepancy and deprivation model of psychosis. Int. Rev. Neurobiol., 2020, 152, 41-69. doi: 10.1016/bs.irn.2019.11.004 PMID: 32451000
  19. Shah, J.L.; Malla, A.K. Much ado about much: Stress, dynamic biomarkers and HPA axis dysregulation along the trajectory to psychosis. Schizophr. Res., 2015, 162(1-3), 253-260. doi: 10.1016/j.schres.2015.01.010 PMID: 25620122
  20. Niemi, L.T.; Suvisaari, J.M.; Tuulio-Henriksson, A.; Lönnqvist, J.K. Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies. Schizophr. Res., 2003, 60(2-3), 239-258. doi: 10.1016/S0920-9964(02)00234-7 PMID: 12591587
  21. Sullivan, P.F.; Kendler, K.S.; Neale, M.C. Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry, 2003, 60(12), 1187-1192. doi: 10.1001/archpsyc.60.12.1187 PMID: 14662550
  22. Rasic, D.; Hajek, T.; Alda, M.; Uher, R. Risk of mental illness in offspring of parents with schizophrenia, bipolar disorder, and major depressive disorder: A meta-analysis of family high-risk studies. Schizophr. Bull., 2014, 40(1), 28-38. doi: 10.1093/schbul/sbt114 PMID: 23960245
  23. Dennison, C.A.; Legge, S.E.; Pardiñas, A.F.; Walters, J.T.R. Genome-wide association studies in schizophrenia: Recent advances, challenges and future perspective. Schizophr. Res., 2020, 217, 4-12. doi: 10.1016/j.schres.2019.10.048 PMID: 31780348
  24. Gottesman, I.I.; Shields, J. Schizophrenia, the epigenetic puzzle; Cambridge University Press: Cambridge, New York, 1982.
  25. Mortensen, P.B.; Pedersen, M.G.; Pedersen, C.B. Psychiatric family history and schizophrenia risk in Denmark: which mental disorders are relevant? Psychol. Med., 2010, 40(2), 201-210. doi: 10.1017/S0033291709990419 PMID: 19607751
  26. Chemerinski, E.; Triebwasser, J.; Roussos, P.; Siever, L.J. Schizotypal personality disorder. J. Pers. Disord., 2013, 27(5), 652-679. doi: 10.1521/pedi_2012_26_053 PMID: 22928856
  27. Rosell, D.R.; Futterman, S.E.; McMaster, A.; Siever, L.J. Schizotypal personality disorder: A current review. Curr. Psychiatry Rep., 2014, 16(7), 452. doi: 10.1007/s11920-014-0452-1 PMID: 24828284
  28. Nordentoft, M.; Thorup, A.; Petersen, L.; Øhlenschlæger, J.; Melau, M.; Christensen, T.Ø.; Krarup, G.; Jørgensen, P.; Jeppesen, P. Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment. Schizophr. Res., 2006, 83(1), 29-40. doi: 10.1016/j.schres.2006.01.002 PMID: 16504481
  29. Woods, S.W.; Addington, J.; Cadenhead, K.S.; Cannon, T.D.; Cornblatt, B.A.; Heinssen, R.; Perkins, D.O.; Seidman, L.J.; Tsuang, M.T.; Walker, E.F.; McGlashan, T.H. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr. Bull., 2009, 35(5), 894-908. doi: 10.1093/schbul/sbp027 PMID: 19386578
  30. Fusar-Poli, P. The clinical high-risk state for psychosis (CHR-P), version II. Schizophr. Bull., 2017, 43(1), 44-47. doi: 10.1093/schbul/sbw158 PMID: 28053129
  31. Catalan, A. Salazar de, P.G.; Aymerich, C.; Damiani, S.; Sordi, V.; Radua, J.; Oliver, D.; McGuire, P.; Giuliano, A.J.; Stone, W.S.; Fusar-Poli, P. Neurocognitive functioning in individuals at clinical high risk for psychosis. JAMA Psychiatry, 2021, 78(8), 859-867. doi: 10.1001/jamapsychiatry.2021.1290 PMID: 34132736
  32. Fusar-Poli, P.; Spencer, T.; De Micheli, A.; Curzi, V.; Nandha, S.; McGuire, P. Outreach and support in South-London (OASIS) 2001—2020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis. Eur. Neuropsychopharmacol., 2020, 39, 111-122. doi: 10.1016/j.euroneuro.2020.08.002 PMID: 32921544
  33. Kotlicka-Antczak, M.; Podgórski, M.; Oliver, D.; Maric, N.P.; Valmaggia, L.; Fusar-Poli, P. Worldwide implementation of clinical services for the prevention of psychosis: The IEPA early intervention in mental health survey. Early Interv. Psychiatry, 2020, 14(6), 741-750. doi: 10.1111/eip.12950 PMID: 32067369
  34. Estradé, A.; Salazar de Pablo, G.; Zanotti, A.; Wood, S.; Fisher, H.L.; Fusar-Poli, P. Public health primary prevention implemented by clinical high-risk services for psychosis. Transl. Psychiatry, 2022, 12(1), 43. doi: 10.1038/s41398-022-01805-4 PMID: 35091529
  35. Salazar de Pablo, G.; Estradé, A.; Cutroni, M.; Andlauer, O.; Fusar-Poli, P. Establishing a clinical service to prevent psychosis: What, how and when? Systematic review. Transl. Psychiatry, 2021, 11(1), 43. doi: 10.1038/s41398-020-01165-x PMID: 33441556
  36. Oliver, D.; Arribas, M.; Radua, J.; Salazar de Pablo, G.; De Micheli, A.; Spada, G.; Mensi, M.M.; Kotlicka-Antczak, M.; Borgatti, R.; Solmi, M.; Shin, J.I.; Woods, S.W.; Addington, J.; McGuire, P.; Fusar-Poli, P. Prognostic accuracy and clinical utility of psychometric instruments for individuals at clinical high-risk of psychosis: A systematic review and meta-analysis. Mol. Psychiatry, 2022, 27(9), 3670-3678. doi: 10.1038/s41380-022-01611-w PMID: 35665763
  37. Salazar de Pablo, G.; Radua, J.; Pereira, J.; Bonoldi, I.; Arienti, V.; Besana, F.; Soardo, L.; Cabras, A.; Fortea, L.; Catalan, A.; Vaquerizo-Serrano, J.; Coronelli, F.; Kaur, S.; Da Silva, J.; Shin, J.I.; Solmi, M.; Brondino, N.; Politi, P.; McGuire, P.; Fusar-Poli, P. Probability of transition to psychosis in individuals at clinical high risk. JAMA Psychiatry, 2021, 78(9), 970-978. doi: 10.1001/jamapsychiatry.2021.0830 PMID: 34259821
  38. Fusar-Poli, P.; Cappucciati, M.; Borgwardt, S.; Woods, S.W.; Addington, J.; Nelson, B.; Nieman, D.H.; Stahl, D.R.; Rutigliano, G.; Riecher-Rössler, A.; Simon, A.E.; Mizuno, M.; Lee, T.Y.; Kwon, J.S.; Lam, M.M.L.; Perez, J.; Keri, S.; Amminger, P.; Metzler, S.; Kawohl, W.; Rössler, W.; Lee, J.; Labad, J.; Ziermans, T.; An, S.K.; Liu, C.C.; Woodberry, K.A.; Braham, A.; Corcoran, C.; McGorry, P.; Yung, A.R.; McGuire, P.K. Heterogeneity of psychosis risk within individuals at clinical high risk. JAMA Psychiatry, 2016, 73(2), 113-120. doi: 10.1001/jamapsychiatry.2015.2324 PMID: 26719911
  39. Provenzani, U.; Salazar de Pablo, G.; Arribas, M.; Pillmann, F.; Fusar-Poli, P. Clinical outcomes in brief psychotic episodes: A systematic review and meta-analysis. Epidemiol. Psychiatr. Sci., 2021, 30, e71. doi: 10.1017/S2045796021000548 PMID: 35698876
  40. Fusar-Poli, P.; Salazar de Pablo, G.; Rajkumar, R.P.; López-Díaz, Á.; Malhotra, S.; Heckers, S.; Lawrie, S.M.; Pillmann, F. Diagnosis, prognosis, and treatment of brief psychotic episodes: A review and research agenda. Lancet Psychiatry, 2022, 9(1), 72-83. doi: 10.1016/S2215-0366(21)00121-8 PMID: 34856200
  41. Minichino, A.; Rutigliano, G.; Merlino, S.; Davies, C.; Oliver, D.; De Micheli, A.; Patel, R.; McGuire, P.; Fusar-Poli, P. Unmet needs in patients with brief psychotic disorders: Too ill for clinical high risk services and not ill enough for first episode services. Eur. Psychiatry, 2019, 57, 26-32. doi: 10.1016/j.eurpsy.2018.12.006 PMID: 30658277
  42. Fusar-Poli, P.; Cappucciati, M.; De Micheli, A.; Rutigliano, G.; Bonoldi, I.; Tognin, S.; Ramella-Cravaro, V.; Castagnini, A.; McGuire, P. Diagnostic and prognostic significance of brief limited intermittent psychotic symptoms (BLIPS) in individuals at ultra high risk. Schizophr. Bull., 2017, 43(1), 48-56. doi: 10.1093/schbul/sbw151 PMID: 28053130
  43. Salazar de Pablo, G.; Besana, F.; Arienti, V.; Catalan, A.; Vaquerizo-Serrano, J.; Cabras, A.; Pereira, J.; Soardo, L.; Coronelli, F.; Kaur, S.; da Silva, J.; Oliver, D.; Petros, N.; Moreno, C.; Gonzalez-Pinto, A.; Díaz-Caneja, C.M.; Shin, J.I.; Politi, P.; Solmi, M.; Borgatti, R.; Mensi, M.M.; Arango, C.; Correll, C.U.; McGuire, P.; Fusar-Poli, P. Longitudinal outcome of attenuated positive symptoms, negative symptoms, functioning and remission in people at clinical high risk for psychosis: A meta-analysis. EClinicalMedicine, 2021, 36, 100909. doi: 10.1016/j.eclinm.2021.100909 PMID: 34189444
  44. Salazar de Pablo, G.; Soardo, L.; Cabras, A.; Pereira, J.; Kaur, S.; Besana, F.; Arienti, V.; Coronelli, F.; Shin, J.I.; Solmi, M.; Petros, N.; Carvalho, A.F.; McGuire, P.; Fusar-Poli, P. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: A meta-analysis. Epidemiol. Psychiatr. Sci., 2022, 31, e9. doi: 10.1017/S2045796021000639 PMID: 35042573
  45. Salazar de Pablo, G.; Woods, S.W.; Drymonitou, G.; de Diego, H.; Fusar-Poli, P. Prevalence of individuals at clinical high-risk of psychosis in the general population and clinical samples: Systematic review and meta-analysis. Brain Sci., 2021, 11(11), 1544. doi: 10.3390/brainsci11111544 PMID: 34827543
  46. Dragioti, E.; Radua, J.; Solmi, M.; Arango, C.; Oliver, D.; Cortese, S.; Jones, P.B.; Il Shin, J.; Correll, C.U.; Fusar-Poli, P. Global population attributable fraction of potentially modifiable risk factors for mental disorders: A meta-umbrella systematic review. Mol. Psychiatry, 2022, 27(8), 3510-3519. doi: 10.1038/s41380-022-01586-8 PMID: 35484237
  47. Perkins, D.O. Evaluating and treating the prodromal stage of schizophrenia. Curr. Psychiatry Rep., 2004, 6(4), 289-295. doi: 10.1007/s11920-004-0079-8 PMID: 15260945
  48. Häfner, H.; Riecher-Rössler, A.; Maurer, K.; Fätkenheuer, B.; Löffler, W. First onset and early symptomatology of schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci., 1992, 242(2-3), 109-118. doi: 10.1007/BF02191557 PMID: 1486099
  49. Norman, R.M.G.; Malla, A.K. Prodromal symptoms of relapse in schizophrenia: A review. Schizophr. Bull., 1995, 21(4), 527-539. doi: 10.1093/schbul/21.4.527 PMID: 8749881
  50. Yung, A.R.; McGorry, P.D. The initial prodrome in psychosis: Descriptive and qualitative aspects. Aust. N. Z. J. Psychiatry, 1996, 30(5), 587-599. doi: 10.3109/00048679609062654 PMID: 8902166
  51. Millan, M.J.; Andrieux, A.; Bartzokis, G.; Cadenhead, K.; Dazzan, P.; Fusar-Poli, P.; Gallinat, J.; Giedd, J.; Grayson, D.R.; Heinrichs, M.; Kahn, R.; Krebs, M.O.; Leboyer, M.; Lewis, D.; Marin, O.; Marin, P.; Meyer-Lindenberg, A.; McGorry, P.; McGuire, P.; Owen, M.J.; Patterson, P.; Sawa, A.; Spedding, M.; Uhlhaas, P.; Vaccarino, F.; Wahlestedt, C.; Weinberger, D. Altering the course of schizophrenia: progress and perspectives. Nat. Rev. Drug Discov., 2016, 15(7), 485-515. doi: 10.1038/nrd.2016.28 PMID: 26939910
  52. Psychosis and schizophrenia in adults: prevention and management. In: NICE Clinical Guidelines; National Institute for Health and Care Excellence (NICE): London, 2014.
  53. Fusar-Poli, P.; Borgwardt, S.; Bechdolf, A.; Addington, J.; Riecher-Rössler, A.; Schultze-Lutter, F.; Keshavan, M.; Wood, S.; Ruhrmann, S.; Seidman, L.J.; Valmaggia, L.; Cannon, T.; Velthorst, E.; De Haan, L.; Cornblatt, B.; Bonoldi, I.; Birchwood, M.; McGlashan, T.; Carpenter, W.; McGorry, P.; Klosterkötter, J.; McGuire, P.; Yung, A. The psychosis high-risk state: A comprehensive state-of-the-art review. JAMA Psychiatry, 2013, 70(1), 107-120. doi: 10.1001/jamapsychiatry.2013.269 PMID: 23165428
  54. Perkins, D.O.; Gu, H.; Boteva, K.; Lieberman, J.A. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: A critical review and meta-analysis. Am. J. Psychiatry, 2005, 162(10), 1785-1804. doi: 10.1176/appi.ajp.162.10.1785 PMID: 16199825
  55. Altamura, A.C.; Serati, M.; Buoli, M. Is duration of illness really influencing outcome in major psychoses? Nord. J. Psychiatry, 2015, 69(6), 1685-1699. doi: 10.3109/08039488.2014.990919 PMID: 25768662
  56. Penttilä, M.; Jääskeläinen, E.; Hirvonen, N.; Isohanni, M.; Miettunen, J. Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: Sstematic review and meta-analysis. Br. J. Psychiatry, 2014, 205(2), 88-94. doi: 10.1192/bjp.bp.113.127753 PMID: 25252316
  57. Boonstra, N.; Klaassen, R.; Sytema, S.; Marshall, M.; De Haan, L.; Wunderink, L.; Wiersma, D. Duration of untreated psychosis and negative symptoms — A systematic review and meta-analysis of individual patient data. Schizophr. Res., 2012, 142(1-3), 12-19. doi: 10.1016/j.schres.2012.08.017 PMID: 23025994
  58. Singh, S.P. Outcome measures in early psychosis. Br. J. Psychiatry, 2007, 191(S50), s58-s63. doi: 10.1192/bjp.191.50.s58 PMID: 18019046
  59. Cuesta, M.J.; García de Jalón, E.; Campos, M.S.; Ibáñez, B.; Sánchez-Torres, A.M.; Peralta, V. Duration of untreated negative and positive symptoms of psychosis and cognitive impairment in first episode psychosis. Schizophr. Res., 2012, 141(2-3), 222-227. doi: 10.1016/j.schres.2012.08.019 PMID: 22989921
  60. Schimmelmann, B.G.; Huber, C.G.; Lambert, M.; Cotton, S.; McGorry, P.D.; Conus, P. Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort. J. Psychiatr. Res., 2008, 42(12), 982-990. doi: 10.1016/j.jpsychires.2007.12.001 PMID: 18199456
  61. Marshall, M.; Lewis, S.; Lockwood, A.; Drake, R.; Jones, P.; Croudace, T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: A systematic review. Arch. Gen. Psychiatry, 2005, 62(9), 975-983. doi: 10.1001/archpsyc.62.9.975 PMID: 16143729
  62. Oliver, D.; Davies, C.; Crossland, G.; Lim, S.; Gifford, G.; McGuire, P.; Fusar-Poli, P. Can we reduce the duration of untreated psychosis? a systematic review and meta-analysis of controlled interventional studies. Schizophr. Bull., 2018, 44(6), 1362-1372. doi: 10.1093/schbul/sbx166 PMID: 29373755
  63. Howes, O.D.; Whitehurst, T.; Shatalina, E.; Townsend, L.; Onwordi, E.C.; Mak, T.L.A.; Arumuham, A.; O’Brien, O.; Lobo, M.; Vano, L.; Zahid, U.; Butler, E.; Osugo, M. The clinical significance of duration of untreated psychosis: An umbrella review and random‐effects meta‐analysis. World Psychiatry, 2021, 20(1), 75-95. doi: 10.1002/wps.20822 PMID: 33432766
  64. van Os, J. ‘Salience syndrome’ replaces ‘schizophrenia’ in DSM-V and ICD-11: psychiatry’s evidence-based entry into the 21st century? Acta Psychiatr. Scand., 2009, 120(5), 363-372. doi: 10.1111/j.1600-0447.2009.01456.x PMID: 19807717
  65. van Os, J.; Hanssen, M.; Bijl, R.V.; Ravelli, A. Strauss (1969) revisited: A psychosis continuum in the general population? Schizophr. Res., 2000, 45(1-2), 11-20. doi: 10.1016/S0920-9964(99)00224-8 PMID: 10978868
  66. van Os, J.; Linscott, R.J. Introduction: The extended psychosis phenotype-relationship with schizophrenia and with ultrahigh risk status for psychosis. Schizophr. Bull., 2012, 38(2), 227-230. doi: 10.1093/schbul/sbr188 PMID: 22355185
  67. Staines, L.; Healy, C.; Coughlan, H.; Clarke, M.; Kelleher, I.; Cotter, D.; Cannon, M. Psychotic experiences in the general population, a review; definition, risk factors, outcomes and interventions. Psychol. Med., 2022, 52(15), 3297-3308. doi: 10.1017/S0033291722002550 PMID: 36004805
  68. Fusar-Poli, P.; Raballo, A.; Parnas, J. What is an attenuated psychotic symptom? on the importance of the context. Schizophr. Bull., 2017, 43(4), 687-692. PMID: 28039421
  69. Linscott, R.J.; van Os, J. An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: On the pathway from proneness to persistence to dimensional expression across mental disorders. Psychol. Med., 2012, 1-17. PMID: 22850401
  70. McGrath, J.J.; Saha, S.; Al-Hamzawi, A.; Alonso, J.; Bromet, E.J.; Bruffaerts, R.; Caldas-de-Almeida, J.M.; Chiu, W.T.; de Jonge, P.; Fayyad, J.; Florescu, S.; Gureje, O.; Haro, J.M.; Hu, C.; Kovess-Masfety, V.; Lepine, J.P.; Lim, C.C.W.; Mora, M.E.M.; Navarro-Mateu, F.; Ochoa, S.; Sampson, N.; Scott, K.; Viana, M.C.; Kessler, R.C. Psychotic experiences in the general population. JAMA Psychiatry, 2015, 72(7), 697-705. doi: 10.1001/jamapsychiatry.2015.0575 PMID: 26018466
  71. Kelleher, I.; Connor, D.; Clarke, M.C.; Devlin, N.; Harley, M.; Cannon, M. Prevalence of psychotic symptoms in childhood and adolescence: A systematic review and meta-analysis of population-based studies. Psychol. Med., 2012, 42(9), 1857-1863. doi: 10.1017/S0033291711002960 PMID: 22225730
  72. De Loore, E.; Gunther, N.; Drukker, M.; Feron, F.; Sabbe, B.; Deboutte, D.; van Os, J.; Myin-Germeys, I. Persistence and outcome of auditory hallucinations in adolescence: A longitudinal general population study of 1800 individuals. Schizophr. Res., 2011, 127(1-3), 252-256. doi: 10.1016/j.schres.2011.01.015 PMID: 21315559
  73. Dominguez, M.D.G.; Wichers, M.; Lieb, R.; Wittchen, H.U.; van Os, J. Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study. Schizophr. Bull., 2011, 37(1), 84-93. doi: 10.1093/schbul/sbp022 PMID: 19460881
  74. Downs, J.M.; Cullen, A.E.; Barragan, M.; Laurens, K.R. Persisting psychotic-like experiences are associated with both externalising and internalising psychopathology in a longitudinal general population child cohort. Schizophr. Res., 2013, 144(1-3), 99-104. doi: 10.1016/j.schres.2012.12.009 PMID: 23321428
  75. Thapar, A.; Heron, J.; Jones, R.B.; Owen, M.J.; Lewis, G.; Zammit, S. Trajectories of change in self-reported psychotic-like experiences in childhood and adolescence. Schizophr. Res., 2012, 140(1-3), 104-109. doi: 10.1016/j.schres.2012.06.024 PMID: 22789670
  76. Healy, C.; Brannigan, R.; Dooley, N.; Coughlan, H.; Clarke, M.; Kelleher, I.; Cannon, M. Childhood and adolescent psychotic experiences and risk of mental disorder: A systematic review and meta-analysis. Psychol. Med., 2019, 49(10), 1589-1599. doi: 10.1017/S0033291719000485 PMID: 31088578
  77. Yates, K.; Lång, U.; Cederlöf, M.; Boland, F.; Taylor, P.; Cannon, M.; McNicholas, F.; DeVylder, J.; Kelleher, I. Association of psychotic experiences with subsequent risk of suicidal ideation, suicide attempts, and suicide deaths. JAMA Psychiatry, 2019, 76(2), 180-189. doi: 10.1001/jamapsychiatry.2018.3514 PMID: 30484818
  78. Schultze-Lutter, F.; Renner, F.; Paruch, J.; Julkowski, D.; Klosterkötter, J.; Ruhrmann, S. Self-reported psychotic-like experiences are a poor estimate of clinician-rated attenuated and frank delusions and hallucinations. Psychopathology, 2014, 47(3), 194-201. doi: 10.1159/000355554 PMID: 24192655
  79. Varese, F.; Smeets, F.; Drukker, M.; Lieverse, R.; Lataster, T.; Viechtbauer, W.; Read, J.; van Os, J.; Bentall, R.P. Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophr. Bull., 2012, 38(4), 661-671. doi: 10.1093/schbul/sbs050 PMID: 22461484
  80. Radua, J.; Ramella-Cravaro, V.; Ioannidis, J.P.A.; Reichenberg, A.; Phiphopthatsanee, N.; Amir, T.; Yenn Thoo, H.; Oliver, D.; Davies, C.; Morgan, C.; McGuire, P.; Murray, R.M.; Fusar-Poli, P. What causes psychosis? An umbrella review of risk and protective factors. World Psychiatry, 2018, 17(1), 49-66. doi: 10.1002/wps.20490 PMID: 29352556
  81. Pastore, A.; de Girolamo, G.; Tafuri, S.; Tomasicchio, A.; Margari, F. Traumatic experiences in childhood and adolescence: A meta-analysis of prospective studies assessing risk for psychosis. Eur. Child Adolesc. Psychiatry, 2022, 31(2), 215-228. doi: 10.1007/s00787-020-01574-9 PMID: 32577908
  82. Davies, C.; Segre, G.; Estradé, A.; Radua, J.; De Micheli, A.; Provenzani, U.; Oliver, D.; Salazar de Pablo, G.; Ramella-Cravaro, V.; Besozzi, M.; Dazzan, P.; Miele, M.; Caputo, G.; Spallarossa, C.; Crossland, G.; Ilyas, A.; Spada, G.; Politi, P.; Murray, R.M.; McGuire, P.; Fusar-Poli, P. Prenatal and perinatal risk and protective factors for psychosis: A systematic review and meta-analysis. Lancet Psychiatry, 2020, 7(5), 399-410. doi: 10.1016/S2215-0366(20)30057-2 PMID: 32220288
  83. Arango, C.; Dragioti, E.; Solmi, M.; Cortese, S.; Domschke, K.; Murray, R.M.; Jones, P.B.; Uher, R.; Carvalho, A.F.; Reichenberg, A.; Shin, J.I.I.; Andreassen, O.A.; Correll, C.U.; Fusar-Poli, P. Risk and protective factors for mental disorders beyond genetics: An evidence‐based atlas. World Psychiatry, 2021, 20(3), 417-436. doi: 10.1002/wps.20894 PMID: 34505386
  84. Pignon, B.; Lajnef, M.; Kirkbride, J.B.; Peyre, H.; Ferchiou, A.; Richard, J.R.; Baudin, G.; Tosato, S.; Jongsma, H.; de Haan, L.; Tarricone, I.; Bernardo, M.; Velthorst, E.; Braca, M.; Arango, C.; Arrojo, M.; Bobes, J.; Del-Ben, C.M.; Di Forti, M.; Gayer-Anderson, C.; Jones, P.B.; La Cascia, C.; Lasalvia, A.; Menezes, P.R.; Quattrone, D.; Sanjuán, J.; Selten, J.P.; Tortelli, A.; Llorca, P.M.; van Os, J.; Rutten, B.P.F.; Murray, R.M.; Morgan, C.; Leboyer, M.; Szöke, A.; Schürhoff, F. The independent effects of psychosocial stressors on subclinical psychosis: Findings from the multinational EU-GEI study. Schizophr. Bull., 2021, 47(6), 1674-1684. doi: 10.1093/schbul/sbab060 PMID: 34009318
  85. Fusar-Poli, P.; Tantardini, M.; De Simone, S.; Ramella-Cravaro, V.; Oliver, D.; Kingdon, J.; Kotlicka-Antczak, M.; Valmaggia, L.; Lee, J.; Millan, M.J.; Galderisi, S.; Balottin, U.; Ricca, V.; McGuire, P. Deconstructing vulnerability for psychosis: Meta-analysis of environmental risk factors for psychosis in subjects at ultra high-risk. Eur. Psychiatry, 2017, 40, 65-75. doi: 10.1016/j.eurpsy.2016.09.003 PMID: 27992836
  86. Kraan, T.C.; Ising, H.K.; Fokkema, M.; Velthorst, E.; van den Berg, D.P.G.; Kerkhoven, M.; Veling, W.; Smit, F.; Linszen, D.H.; Nieman, D.H.; Wunderink, L.; Boonstra, N.; Klaassen, R.M.C.; Dragt, S.; Rietdijk, J.; de Haan, L.; van der Gaag, M. The effect of childhood adversity on 4-year outcome in individuals at ultra high risk for psychosis in the dutch early detection intervention evaluation (EDIE-NL) trial. Psychiatry Res., 2017, 247, 55-62. doi: 10.1016/j.psychres.2016.11.014 PMID: 27863320
  87. Kraan, T.C.; Velthorst, E.; Themmen, M.; Valmaggia, L.; Kempton, M.J.; McGuire, P.; van Os, J.; Rutten, B.P.F.; Smit, F.; de Haan, L.; van der Gaag, M.; Study, E.U.G.E.I.H.R. Child maltreatment and clinical outcome in individuals at ultra-high risk for psychosis in the EU-GEI high risk study. Schizophr. Bull., 2018, 44(3), 584-592. doi: 10.1093/schbul/sbw162 PMID: 28666366
  88. Peh, O.H.; Rapisarda, A.; Lee, J. Childhood adversities in people at ultra-high risk (UHR) for psychosis: A systematic review and meta-analysis. Psychol. Med., 2019, 49(7), 1089-1101. doi: 10.1017/S003329171800394X PMID: 30616701
  89. Liu, Y.; Mendonça, M.; Cannon, M.; Jones, P.B.; Lewis, G.; Thompson, A.; Zammit, S.; Wolke, D. Testing the independent and joint contribution of exposure to neurodevelopmental adversity and childhood trauma to risk of psychotic experiences in adulthood. Schizophr. Bull., 2021, 47(3), 776-784. doi: 10.1093/schbul/sbaa174 PMID: 33331643
  90. Lataster, J.; Myin-Germeys, I.; Lieb, R.; Wittchen, H.U.; van Os, J. Adversity and psychosis: A 10-year prospective study investigating synergism between early and recent adversity in psychosis. Acta Psychiatr. Scand., 2012, 125(5), 388-399. doi: 10.1111/j.1600-0447.2011.01805.x PMID: 22128839
  91. Brown, G.W.; Birley, J.L.T. Crises and life changes and the onset of schizophrenia. J. Health Soc. Behav., 1968, 9(3), 203-214. doi: 10.2307/2948405 PMID: 5676853
  92. Beards, S.; Gayer-Anderson, C.; Borges, S.; Dewey, M.E.; Fisher, H.L.; Morgan, C. Life events and psychosis: A review and meta-analysis. Schizophr. Bull., 2013, 39(4), 740-747. doi: 10.1093/schbul/sbt065 PMID: 23671196
  93. Cullen, A.E.; Fisher, H.L.; Roberts, R.E.; Pariante, C.M.; Laurens, K.R. Daily stressors and negative life events in children at elevated risk of developing schizophrenia. Br. J. Psychiatry, 2014, 204(5), 354-360. doi: 10.1192/bjp.bp.113.127001 PMID: 24627296
  94. Trotman, H.D.; Holtzman, C.W.; Walker, E.F.; Addington, J.M.; Bearden, C.E.; Cadenhead, K.S.; Cannon, T.D.; Cornblatt, B.A.; Heinssen, R.K.; Mathalon, D.H.; Tsuang, M.T.; Perkins, D.O.; Seidman, L.J.; Woods, S.W.; McGlashan, T.H. Stress exposure and sensitivity in the clinical high-risk syndrome: Initial findings from the North American Prodrome Longitudinal Study (NAPLS). Schizophr. Res., 2014, 160(1-3), 104-109. doi: 10.1016/j.schres.2014.09.017 PMID: 25443665
  95. Cullen, A.E.; Addington, J.; Bearden, C.E.; Stone, W.S.; Seidman, L.J.; Cadenhead, K.S.; Cannon, T.D.; Cornblatt, B.A.; Mathalon, D.H.; McGlashan, T.H.; Perkins, D.O.; Tsuang, M.T.; Woods, S.W.; Walker, E.F. Stressor-cortisol concordance among individuals at clinical high-risk for psychosis: Novel findings from the NAPLS cohort. Psychoneuroendocrinology, 2020, 115, 104649. doi: 10.1016/j.psyneuen.2020.104649 PMID: 32197198
  96. Cannon, T.D.; Yu, C.; Addington, J.; Bearden, C.E.; Cadenhead, K.S.; Cornblatt, B.A.; Heinssen, R.; Jeffries, C.D.; Mathalon, D.H.; McGlashan, T.H.; Perkins, D.O.; Seidman, L.J.; Tsuang, M.T.; Walker, E.F.; Woods, S.W.; Kattan, M.W. An individualized risk calculator for research in prodromal psychosis. Am. J. Psychiatry, 2016, 173(10), 980-988. doi: 10.1176/appi.ajp.2016.15070890 PMID: 27363508
  97. Solhan, M.B.; Trull, T.J.; Jahng, S.; Wood, P.K. Clinical assessment of affective instability: Comparing EMA indices, questionnaire reports, and retrospective recall. Psychol. Assess., 2009, 21(3), 425-436. doi: 10.1037/a0016869 PMID: 19719353
  98. Larson, R.; Csikszentmihalyi, M. The experience sampling method. In: Flow and the Foundations of Positive Psychology; Springer: Dordrecht, 2014. doi: 10.1007/978-94-017-9088-8_2
  99. Shiffman, S.; Stone, A.A.; Hufford, M.R. Ecological momentary assessment. Annu. Rev. Clin. Psychol., 2008, 4(1), 1-32. doi: 10.1146/annurev.clinpsy.3.022806.091415 PMID: 18509902
  100. Wright, A.C.; Browne, J.; Skiest, H.; Bhiku, K.; Baker, J.T.; Cather, C. The relationship between conventional clinical assessments and momentary assessments of symptoms and functioning in schizophrenia spectrum disorders: A systematic review. Schizophr. Res., 2021, 232, 11-27. doi: 10.1016/j.schres.2021.04.010 PMID: 34004382
  101. Bell, I.H.; Lim, M.H.; Rossell, S.L.; Thomas, N. Ecological momentary assessment and intervention in the treatment of psychotic disorders: A systematic review. Psychiatr. Serv., 2017, 68(11), 1172-1181. doi: 10.1176/appi.ps.201600523 PMID: 28669284
  102. Myin-Germeys, I.; van Os, J.; Schwartz, J.E.; Stone, A.A.; Delespaul, P.A. Emotional reactivity to daily life stress in psychosis. Arch. Gen. Psychiatry, 2001, 58(12), 1137-1144. doi: 10.1001/archpsyc.58.12.1137 PMID: 11735842
  103. Myin-Germeys, I.; Delespaul, P.H.; Van Os, J. Behavioural sensitization to daily life stress in psychosis. Psychol. Med., 2005, 35(5), 733-741. doi: 10.1017/S0033291704004179 PMID: 15918350
  104. Palmier-Claus, J.E.; Dunn, G.; Lewis, S.W. Emotional and symptomatic reactivity to stress in individuals at ultra-high risk of developing psychosis. Psychol. Med., 2012, 42(5), 1003-1012. doi: 10.1017/S0033291711001929 PMID: 22067414
  105. Paetzold, I.; Myin-Germeys, I.; Schick, A.; Nelson, B.; Velthorst, E.; Schirmbeck, F.; van Os, J.; Morgan, C.; Hartmann, J.; van der Gaag, M.; de Haan, L.; Valmaggia, L.; McGuire, P.; Kempton, M.; Reininghaus, U. Stress reactivity as a putative mechanism linking childhood trauma with clinical outcomes in individuals at ultra-high-risk for psychosis: Findings from the EU-GEI High Risk Study. Epidemiol. Psychiatr. Sci., 2021, 30, e40. doi: 10.1017/S2045796021000251 PMID: 34044905
  106. Collip, D.; Wigman, J.T.W.; Myin-Germeys, I.; Jacobs, N.; Derom, C.; Thiery, E.; Wichers, M.; van Os, J. From epidemiology to daily life: linking daily life stress reactivity to persistence of psychotic experiences in a longitudinal general population study. PLoS One, 2013, 8(4), e62688. doi: 10.1371/journal.pone.0062688 PMID: 23626848
  107. Anglin, D.M.; Ereshefsky, S.; Klaunig, M.J.; Bridgwater, M.A.; Niendam, T.A.; Ellman, L.M.; DeVylder, J.; Thayer, G.; Bolden, K.; Musket, C.W.; Grattan, R.E.; Lincoln, S.H.; Schiffman, J.; Lipner, E.; Bachman, P.; Corcoran, C.M.; Mota, N.B.; van der Ven, E. From womb to neighborhood: A racial analysis of social determinants of psychosis in the United States. Am. J. Psychiatry, 2021, 178(7), 599-610. doi: 10.1176/appi.ajp.2020.20071091 PMID: 33934608
  108. Betancourt, T.S.; Newnham, E.A.; Birman, D.; Lee, R.; Ellis, B.H.; Layne, C.M. Comparing trauma exposure, mental health needs, and service utilization across clinical samples of refugee, immigrant, and u.s.-origin children. J. Trauma. Stress, 2017, 30(3), 209-218. doi: 10.1002/jts.22186 PMID: 28585740
  109. Eisenman, D.P.; Gelberg, L.; Liu, H.; Shapiro, M.F. Mental health and health-related quality of life among adult Latino primary care patients living in the United States with previous exposure to political violence. JAMA, 2003, 290(5), 627-634. doi: 10.1001/jama.290.5.627 PMID: 12902366
  110. Cleary, S.D.; Snead, R.; Dietz-Chavez, D.; Rivera, I.; Edberg, M.C. Immigrant trauma and mental health outcomes among latino youth. J. Immigr. Minor. Health, 2018, 20(5), 1053-1059. doi: 10.1007/s10903-017-0673-6 PMID: 29139024
  111. Lopez, D.; Altamirano, O.; Weisman de Mamani, A. The association between perceived racial discrimination and subclinical symptoms of psychosis. J. Ment. Health, 2022, 31(1), 14-21. doi: 10.1080/09638237.2020.1793120 PMID: 32662709
  112. Fusar-Poli, P.; Rutigliano, G.; Stahl, D.; Schmidt, A.; Ramella-Cravaro, V.; Hitesh, S.; McGuire, P. Deconstructing pretest risk enrichment to optimize prediction of psychosis in individuals at clinical high risk. JAMA Psychiatry, 2016, 73(12), 1260-1267. doi: 10.1001/jamapsychiatry.2016.2707 PMID: 27784037
  113. Oliver, D.; Reilly, T.J.; Baccaredda Boy, O.; Petros, N.; Davies, C.; Borgwardt, S.; McGuire, P.; Fusar-Poli, P. What causes the onset of psychosis in individuals at clinical high risk? a meta-analysis of risk and protective factors. Schizophr. Bull., 2022, 46(1), 110-120. PMID: 31219164
  114. Thompson, J.L.; Kelly, M.; Kimhy, D.; Harkavy-Friedman, J.M.; Khan, S.; Messinger, J.W.; Schobel, S.; Goetz, R.; Malaspina, D.; Corcoran, C. Childhood trauma and prodromal symptoms among individuals at clinical high risk for psychosis. Schizophr. Res., 2009, 108(1-3), 176-181. doi: 10.1016/j.schres.2008.12.005 PMID: 19174322
  115. Geros, H.; Sizer, H.; Mifsud, N.; Reynolds, S.; Kim, D.J.; Eaton, S.; McGorry, P.; Nelson, B.; O’Donoghue, B. Migrant status and identification as ultra‐high risk for psychosis and transitioning to a psychotic disorder. Acta Psychiatr. Scand., 2020, 141(1), 52-59. doi: 10.1111/acps.13099 PMID: 31520527
  116. Moore, D.; Castagnini, E.; Mifsud, N.; Geros, H.; Sizer, H.; Addington, J.; van der Gaag, M.; Nelson, B.; McGorry, P.; O’Donoghue, B. The associations between migrant status and ethnicity and the identification of individuals at ultra-high risk for psychosis and transition to psychosis: A systematic review. Soc. Psychiatry Psychiatr. Epidemiol., 2021, 56(11), 1923-1941. doi: 10.1007/s00127-021-02047-3 PMID: 33641006
  117. Nerhus, M.; Berg, A.O.; Haram, M.; Kvitland, L.R.; Andreassen, O.A.; Melle, I. Migrant background and ethnic minority status as predictors for duration of untreated psychosis. Early Interv. Psychiatry, 2015, 9(1), 61-65. doi: 10.1111/eip.12106 PMID: 24225002
  118. Boonstra, N.; Sterk, B.; Wunderink, L.; Sytema, S.; De Haan, L.; Wiersma, D. Association of treatment delay, migration and urbanicity in psychosis. Eur. Psychiatry, 2012, 27(7), 500-505. doi: 10.1016/j.eurpsy.2011.05.001 PMID: 21705200
  119. Lindert, J.; Schouler-Ocak, M.; Heinz, A.; Priebe, S. Mental health, health care utilisation of migrants in Europe. Eur. Psychiatry, 2008, 23(S1), s114-s20. doi: 10.1016/S0924-9338(08)70057-9 PMID: 18371575
  120. Jensen, N.K.; Norredam, M.; Priebe, S.; Krasnik, A. How do general practitioners experience providing care to refugees with mental health problems? A qualitative study from Denmark. BMC Fam. Pract., 2013, 14(1), 17. doi: 10.1186/1471-2296-14-17 PMID: 23356401
  121. Vargas, T.; Damme, K.S.F.; Osborne, K.J.; Mittal, V.A. Differentiating kinds of systemic stressors with relation to psychotic-like experiences in late childhood and early adolescence: the stimulation, discrepancy, and deprivation model of psychosis. Clin. Psychol. Sci., 2022, 10(2), 291-309. doi: 10.1177/21677026211016415 PMID: 35402089
  122. Robinson, T.; Ali, M.U.; Easterbrook, B.; Hall, W.; Jutras-Aswad, D.; Fischer, B. Risk-thresholds for the association between frequency of cannabis use and the development of psychosis: A systematic review and meta-analysis. Psychol. Med., 2022, 1-11. doi: 10.1017/S0033291722000502 PMID: 35321777
  123. Orsolini, L.; Chiappini, S.; Papanti, D.; De Berardis, D.; Corkery, J.M.; Schifano, F. The bridge between classical and "synthetic"/chemical psychoses: Towards a clinical, psychopathological, and therapeutic perspective. Front. Psychiatry, 2019, 10, 851. doi: 10.3389/fpsyt.2019.00851 PMID: 31849723
  124. Hjorthøj, C.; Larsen, M.O.; Starzer, M.S.K.; Nordentoft, M. Annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in Denmark from 1994 to 2016. Psychol. Med., 2021, 51(4), 617-622. doi: 10.1017/S0033291719003532 PMID: 31839011
  125. Rognli, E.B.; Taipale, H.; Hjorthøj, C.; Mittendorfer-Rutz, E.; Bramness, J.G.; Heiberg, I.H.; Niemelä, S. Annual incidence of substance-induced psychoses in Scandinavia from 2000 to 2016. Psychol. Med., 2022, 1-10. doi: 10.1017/S003329172200229X PMID: 35983644
  126. De Berardis, D.; De Filippis, S.; Masi, G.; Vicari, S.; Zuddas, A. A neurodevelopment approach for a transitional model of early onset schizophrenia. Brain Sci., 2021, 11(2), 275. doi: 10.3390/brainsci11020275 PMID: 33672396
  127. van der Steur, S.J.; Batalla, A.; Bossong, M.G. Factors moderating the association between cannabis use and psychosis risk: A systematic review. Brain Sci., 2020, 10(2), 97. doi: 10.3390/brainsci10020097 PMID: 32059350
  128. Barzilay, R.; Pries, L.K.; Moore, T.M.; Gur, R.E.; van Os, J.; Rutten, B.P.F.; Guloksuz, S. Exposome and trans-syndromal developmental trajectories toward psychosis. Biol. Psychiatry Global Open Sci., 2022, 2(3), 197-205. doi: 10.1016/j.bpsgos.2022.05.001 PMID: 36325037
  129. Cougnard, A.; Marcelis, M.; Myin-Germeys, I.; De Graaf, R.; Vollebergh, W.; Krabbendam, L.; Lieb, R.; Wittchen, H.U.; Henquet, C.; Spauwen, J.; Van Os, J. Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness–persistence model. Psychol. Med., 2007, 37(4), 513-527. doi: 10.1017/S0033291706009731 PMID: 17288646
  130. Carlyle, M.; Constable, T.; Walter, Z.C.; Wilson, J.; Newland, G.; Hides, L. Cannabis-induced dysphoria/paranoia mediates the link between childhood trauma and psychotic-like experiences in young cannabis users. Schizophr. Res., 2021, 238, 178-184. doi: 10.1016/j.schres.2021.10.011 PMID: 34717186
  131. Harley, M.; Kelleher, I.; Clarke, M.; Lynch, F.; Arseneault, L.; Connor, D.; Fitzpatrick, C.; Cannon, M. Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence. Psychol. Med., 2010, 40(10), 1627-1634. doi: 10.1017/S0033291709991966 PMID: 19995476
  132. Day, F.; Pariante, C.M. Stress and cortisol in the pre-psychotic phases.Vulnerability to psychosis: from neurosciences to psychopathology Fusar-Poli, P.; Borgwardt, S.; McGuire, P., Eds.; Psychology Press: Hove, East Sussex ; , 2012.
  133. Krugers, H.J.; Karst, H.; Joels, M. Interactions between noradrenaline and corticosteroids in the brain: from electrical activity to cognitive performance. Front. Cell. Neurosci., 2012, 6, 15. doi: 10.3389/fncel.2012.00015 PMID: 22509154
  134. Laryea, G.; Schütz, G.; Muglia, L.J. Disrupting hypothalamic glucocorticoid receptors causes HPA axis hyperactivity and excess adiposity. Mol. Endocrinol., 2013, 27(10), 1655-1665. doi: 10.1210/me.2013-1187 PMID: 23979842
  135. Pariante, C.M. Pituitary volume in psychosis: the first review of the evidence. J. Psychopharmacol., 2008, 22(S2), 76-81. doi: 10.1177/0269881107084020 PMID: 18709702
  136. Zipursky, A.R.; Whittle, S.; Yücel, M.; Lorenzetti, V.; Wood, S.J.; Lubman, D.I.; Simmons, J.G.; Allen, N.B. Pituitary volume prospectively predicts internalizing symptoms in adolescence. J. Child Psychol. Psychiatry, 2011, 52(3), 315-323. doi: 10.1111/j.1469-7610.2010.02337.x PMID: 21073460
  137. Girshkin, L.; Matheson, S.L.; Shepherd, A.M.; Green, M.J. Morning cortisol levels in schizophrenia and bipolar disorder: A meta-analysis. Psychoneuroendocrinology, 2014, 49, 187-206. doi: 10.1016/j.psyneuen.2014.07.013 PMID: 25108162
  138. Misiak, B.; Pruessner, M.; Samochowiec, J.; Wiśniewski, M.; Reginia, A.; Stańczykiewicz, B. A meta-analysis of blood and salivary cortisol levels in first-episode psychosis and high-risk individuals. Front. Neuroendocrinol., 2021, 62, 100930. doi: 10.1016/j.yfrne.2021.100930 PMID: 34171354
  139. Hubbard, D.B.; Miller, B.J. Meta-analysis of blood cortisol levels in individuals with first-episode psychosis. Psychoneuroendocrinology, 2019, 104, 269-275. doi: 10.1016/j.psyneuen.2019.03.014 PMID: 30909008
  140. Ciufolini, S.; Dazzan, P.; Kempton, M.J.; Pariante, C.; Mondelli, V. HPA axis response to social stress is attenuated in schizophrenia but normal in depression: Evidence from a meta-analysis of existing studies. Neurosci. Biobehav. Rev., 2014, 47, 359-368. doi: 10.1016/j.neubiorev.2014.09.004 PMID: 25246294
  141. Zorn, J.V.; Schür, R.R.; Boks, M.P.; Kahn, R.S.; Joëls, M.; Vinkers, C.H. Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis. Psychoneuroendocrinology, 2017, 77, 25-36. doi: 10.1016/j.psyneuen.2016.11.036 PMID: 28012291
  142. Berger, M.; Kraeuter, A.K.; Romanik, D.; Malouf, P.; Amminger, G.P.; Sarnyai, Z. Cortisol awakening response in patients with psychosis: Systematic review and meta-analysis. Neurosci. Biobehav. Rev., 2016, 68, 157-166. doi: 10.1016/j.neubiorev.2016.05.027 PMID: 27229759
  143. Dauvermann, M.R.; Donohoe, G. Cortisol stress response in psychosis from the high-risk to the chronic stage: A systematic review. Ir. J. Psychol. Med., 2019, 36(4), 305-315. doi: 10.1017/ipm.2019.27 PMID: 31317845
  144. Andrade, E.H.; Rizzo, L.B.; Noto, C.; Ota, V.K.; Gadelha, A.; Daruy-Filho, L.; Tasso, B.C.; Mansur, R.B.; Cordeiro, Q.; Belangero, S.I.; Bressan, R.A.; Grassi-Oliveira, R.; Brietzke, E. Hair cortisol in drug-naïve first-episode individuals with psychosis. Rev. Bras. Psiquiatr., 2016, 38(1), 11-16. doi: 10.1590/1516-4446-2014-1634 PMID: 26814837
  145. van den Heuvel, L.L.; Smit, A.M.; Stalder, T.; Kirschbaum, C.; Seedat, S.; Emsley, R. Hair cortisol levels in schizophrenia and metabolic syndrome. Early Interv. Psychiatry, 2022, 16(8), 902-911. doi: 10.1111/eip.13238 PMID: 34978366
  146. Chaumette, B.; Kebir, O.; Mam-Lam-Fook, C.; Morvan, Y.; Bourgin, J.; Godsil, B.P.; Plaze, M.; Gaillard, R.; Jay, T.M.; Krebs, M.O. Salivary cortisol in early psychosis: New findings and meta-analysis. Psychoneuroendocrinology, 2016, 63, 262-270. doi: 10.1016/j.psyneuen.2015.10.007 PMID: 26520686
  147. Pruessner, M.; Béchard-Evans, L.; Boekestyn, L.; Iyer, S.N.; Pruessner, J.C.; Malla, A.K. Attenuated cortisol response to acute psychosocial stress in individuals at ultra-high risk for psychosis. Schizophr. Res., 2013, 146(1-3), 79-86. doi: 10.1016/j.schres.2013.02.019 PMID: 23510595
  148. Walter, E.E.; Fernandez, F.; Snelling, M.; Barkus, E. Stress induced cortisol release and schizotypy. Psychoneuroendocrinology, 2018, 89, 209-215. doi: 10.1016/j.psyneuen.2018.01.012 PMID: 29414034
  149. van Leeuwen, J.M.C.; Vink, M.; Fernández, G.; Hermans, E.J.; Joëls, M.; Kahn, R.S.; Vinkers, C.H. At-risk individuals display altered brain activity following stress. Neuropsychopharmacology, 2018, 43(9), 1954-1960. doi: 10.1038/s41386-018-0026-8 PMID: 29483659
  150. Heinze, K.; Lin, A.; Reniers, R.L.E.P.; Wood, S.J. Longer-term increased cortisol levels in young people with mental health problems. Psychiatry Res., 2016, 236, 98-104. doi: 10.1016/j.psychres.2015.12.025 PMID: 26749569
  151. Söder, E.; Clamor, A.; Lincoln, T.M. Hair cortisol concentrations as an indicator of potential HPA axis hyperactivation in risk for psychosis. Schizophr. Res., 2019, 212, 54-61. doi: 10.1016/j.schres.2019.08.012 PMID: 31455519
  152. Worthington, M.A.; Walker, E.F.; Addington, J.; Bearden, C.E.; Cadenhead, K.S.; Cornblatt, B.A.; Mathalon, D.H.; McGlashan, T.H.; Perkins, D.O.; Seidman, L.J.; Tsuang, M.T.; Woods, S.W.; Cannon, T.D. Incorporating cortisol into the NAPLS2 individualized risk calculator for prediction of psychosis. Schizophr. Res., 2021, 227, 95-100. doi: 10.1016/j.schres.2020.09.022 PMID: 33046334
  153. Cullen, A.E.; Fisher, H.L.; Gullet, N.; Fraser, E.R.; Roberts, R.E.; Zahid, U.; To, M.; Yap, N.H.; Zunszain, P.A.; Pariante, C.M.; Wood, S.J.; McGuire, P.; Murray, R.M.; Mondelli, V.; Laurens, K.R. Cortisol levels in childhood associated with emergence of attenuated psychotic symptoms in early adulthood. Biol. Psychiatry, 2022, 91(2), 226-235. doi: 10.1016/j.biopsych.2021.08.009 PMID: 34715990
  154. Nordholm, D.; Krogh, J.; Mondelli, V.; Dazzan, P.; Pariante, C.; Nordentoft, M. Pituitary gland volume in patients with schizophrenia, subjects at ultra high-risk of developing psychosis and healthy controls: A systematic review and meta-analysis. Psychoneuroendocrinology, 2013, 38(11), 2394-2404. doi: 10.1016/j.psyneuen.2013.06.030 PMID: 23890984
  155. Saunders, T.S.; Mondelli, V.; Cullen, A.E. Pituitary volume in individuals at elevated risk for psychosis: A systematic review and meta-analysis. Schizophr. Res., 2019, 213, 23-31. doi: 10.1016/j.schres.2018.12.026 PMID: 30600112
  156. Garner, B.; Pariante, C.M.; Wood, S.J.; Velakoulis, D.; Phillips, L.; Soulsby, B.; Brewer, W.J.; Smith, D.J.; Dazzan, P.; Berger, G.E.; Yung, A.R.; van den Buuse, M.; Murray, R.; McGorry, P.D.; Pantelis, C. Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol. Psychiatry, 2005, 58(5), 417-423. doi: 10.1016/j.biopsych.2005.04.018 PMID: 16026767
  157. Cullen, A.E.; Rai, S.; Vaghani, M.S.; Mondelli, V.; McGuire, P. Cortisol responses to naturally occurring psychosocial stressors across the psychosis spectrum: A systematic review and meta-analysis. Front. Psychiatry, 2020, 11(11), 513. doi: 10.3389/fpsyt.2020.00513 PMID: 32595532
  158. Collip, D.; Nicolson, N.A.; Lardinois, M.; Lataster, T.; van Os, J.; Myin-Germeys, I. Daily cortisol, stress reactivity and psychotic experiences in individuals at above average genetic risk for psychosis. Psychol. Med., 2011, 41(11), 2305-2315. doi: 10.1017/S0033291711000602 PMID: 21733219
  159. Vaessen, T.; Kasanova, Z.; Hernaus, D.; Lataster, J.; Collip, D.; van Nierop, M.; Myin-Germeys, I. Overall cortisol, diurnal slope, and stress reactivity in psychosis: An experience sampling approach. Psychoneuroendocrinology, 2018, 96, 61-68. doi: 10.1016/j.psyneuen.2018.06.007 PMID: 29906787
  160. Leboyer, M.; Oliveira, J.; Tamouza, R.; Groc, L. Is it time for immunopsychiatry in psychotic disorders? Psychopharmacology, 2016, 233(9), 1651-1660. doi: 10.1007/s00213-016-4266-1 PMID: 26988846
  161. Zefferino, R.; Di Gioia, S.; Conese, M. Molecular links between endocrine, nervous and immune system during chronic stress. Brain Behav., 2021, 11(2), e01960. doi: 10.1002/brb3.1960 PMID: 33295155
  162. Mondelli, V. From stress to psychosis: Whom, how, when and why? Epidemiol. Psychiatr. Sci., 2014, 23(3), 215-218. doi: 10.1017/S204579601400033X PMID: 24905592
  163. Orsolini, L.; Sarchione, F.; Vellante, F.; Fornaro, M.; Matarazzo, I.; Martinotti, G.; Valchera, A.; Di Nicola, M.; Carano, A.; Di Giannantonio, M.; Perna, G.; Olivieri, L.; De Berardis, D. Protein-C reactive as biomarker predictor of schizophrenia phases of illness? a systematic review. Curr. Neuropharmacol., 2018, 16(5), 583-606. doi: 10.2174/1570159X16666180119144538 PMID: 29357805
  164. Heurich, M.; Föcking, M.; Mongan, D.; Cagney, G.; Cotter, D.R. Dysregulation of complement and coagulation pathways: Emerging mechanisms in the development of psychosis. Mol. Psychiatry, 2022, 27(1), 127-140. doi: 10.1038/s41380-021-01197-9 PMID: 34226666
  165. Al-Diwani, A.A.J.; Pollak, T.A.; Irani, S.R.; Lennox, B.R. Psychosis: An autoimmune disease? Immunology, 2017, 152(3), 388-401. doi: 10.1111/imm.12795 PMID: 28704576
  166. Choudhury, Z.; Lennox, B. Maternal immune activation and schizophrenia–evidence for an immune priming disorder. Front. Psychiatry, 2021, 12, 585742. doi: 10.3389/fpsyt.2021.585742 PMID: 33679468
  167. Carlsson, E.; Frostell, A.; Ludvigsson, J.; Faresjö, M. Psychological stress in children may alter the immune response. J. Immunol., 2014, 192(5), 2071-2081. doi: 10.4049/jimmunol.1301713 PMID: 24501202
  168. Khandaker, G.M.; Pearson, R.M.; Zammit, S.; Lewis, G.; Jones, P.B. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: A population-based longitudinal study. JAMA Psychiatry, 2014, 71(10), 1121-1128. doi: 10.1001/jamapsychiatry.2014.1332 PMID: 25133871
  169. Föcking, M.; Sabherwal, S.; Cates, H.M.; Scaife, C.; Dicker, P.; Hryniewiecka, M.; Wynne, K.; Rutten, B.P.F.; Lewis, G.; Cannon, M.; Nestler, E.J.; Heurich, M.; Cagney, G.; Zammit, S.; Cotter, D.R. Complement pathway changes at age 12 are associated with psychotic experiences at age 18 in a longitudinal population-based study: Evidence for a role of stress. Mol. Psychiatry, 2021, 26(2), 524-533. doi: 10.1038/s41380-018-0306-z PMID: 30635638
  170. Pillinger, T.; Osimo, E.F.; Brugger, S.; Mondelli, V.; McCutcheon, R.A.; Howes, O.D. A meta-analysis of immune parameters, variability, and assessment of modal distribution in psychosis and test of the immune subgroup hypothesis. Schizophr. Bull., 2019, 45(5), 1120-1133. doi: 10.1093/schbul/sby160 PMID: 30407606
  171. Miller, B.J.; Gassama, B.; Sebastian, D.; Buckley, P.; Mellor, A. Meta-analysis of lymphocytes in schizophrenia: Clinical status and antipsychotic effects. Biol. Psychiatry, 2013, 73(10), 993-999. doi: 10.1016/j.biopsych.2012.09.007 PMID: 23062357
  172. Miller, B.J.; Buckley, P.; Seabolt, W.; Mellor, A.; Kirkpatrick, B. Meta-analysis of cytokine alterations in schizophrenia: Clinical status and antipsychotic effects. Biol. Psychiatry, 2011, 70(7), 663-671. doi: 10.1016/j.biopsych.2011.04.013 PMID: 21641581
  173. Mondelli, V.; Ciufolini, S.; Belvederi Murri, M.; Bonaccorso, S.; Di Forti, M.; Giordano, A.; Marques, T.R.; Zunszain, P.A.; Morgan, C.; Murray, R.M.; Pariante, C.M.; Dazzan, P. Cortisol and inflammatory biomarkers predict poor treatment response in first episode psychosis. Schizophr. Bull., 2015, 41(5), 1162-1170. doi: 10.1093/schbul/sbv028 PMID: 25829375
  174. Steiner, J.; Jacobs, R.; Panteli, B.; Brauner, M.; Schiltz, K.; Bahn, S.; Herberth, M.; Westphal, S.; Gos, T.; Walter, M.; Bernstein, H.G.; Myint, A.M.; Bogerts, B. Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity. Eur. Arch. Psychiatry Clin. Neurosci., 2010, 260(7), 509-518. doi: 10.1007/s00406-010-0098-x PMID: 20107825
  175. Di Nicola, M.; Cattaneo, A.; Hepgul, N.; Di Forti, M.; Aitchison, K.J.; Janiri, L.; Murray, R.M.; Dazzan, P.; Pariante, C.M.; Mondelli, V. Serum and gene expression profile of cytokines in first-episode psychosis. Brain Behav. Immun., 2013, 31, 90-95. doi: 10.1016/j.bbi.2012.06.010 PMID: 22749891
  176. Corsi-Zuelli, F.; Loureiro, C.M.; Shuhama, R.; Fachim, H.A.; Menezes, P.R.; Louzada-Junior, P.; Mondelli, V.; Del-Ben, C.M. Cytokine profile in first-episode psychosis, unaffected siblings and community-based controls: The effects of familial liability and childhood maltreatment. Psychol. Med., 2020, 50(7), 1139-1147. doi: 10.1017/S0033291719001016 PMID: 31064423
  177. Misiak, B.; Bartoli, F.; Carrà, G.; Stańczykiewicz, B.; Gładka, A.; Frydecka, D.; Samochowiec, J.; Jarosz, K.; Hadryś, T.; Miller, B.J. Immune-inflammatory markers and psychosis risk: A systematic review and meta-analysis. Psychoneuroendocrinology, 2021, 127, 105200. doi: 10.1016/j.psyneuen.2021.105200 PMID: 33740587
  178. Perkins, D.O.; Jeffries, C.D.; Addington, J.; Bearden, C.E.; Cadenhead, K.S.; Cannon, T.D.; Cornblatt, B.A.; Mathalon, D.H.; McGlashan, T.H.; Seidman, L.J.; Tsuang, M.T.; Walker, E.F.; Woods, S.W.; Heinssen, R. Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: Preliminary results from the NAPLS project. Schizophr. Bull., 2015, 41(2), 419-428. doi: 10.1093/schbul/sbu099 PMID: 25103207
  179. Mongan, D.; Focking, M.; Healy, C.; Susai, S.R.; Heurich, M.; Wynne, K.; Nelson, B.; McGorry, P.D.; Amminger, G.P.; Nordentoft, M.; Krebs, M.O.; Riecher-Rossler, A.; Bressan, R.A.; Barrantes-Vidal, N.; Borgwardt, S.; Ruhrmann, S.; Sachs, G.; Pantelis, C.; van der Gaag, M.; de Haan, L.; Valmaggia, L.; Pollak, T.A.; Kempton, M.J.; Rutten, B.P.F.; Whelan, R.; Cannon, M.; Zammit, S.; Cagney, G.; Cotter, D.R.; McGuire, P. European network of national schizophrenia networks studying gene-environment interactions high risk study, g. development of proteomic prediction models for transition to psychotic disorder in the clinical high-risk state and psychotic experiences in adolescence. JAMA Psychiatry, 2021, 78(1), 77-90. doi: 10.1001/jamapsychiatry.2020.2459 PMID: 32857162
  180. Pollak, T.A.; Kempton, M.J.; Iyegbe, C.; Vincent, A.; Irani, S.R.; Coutinho, E.; Menassa, D.A.; Jacobson, L.; de Haan, L.; Ruhrmann, S.; Sachs, G.; Riecher-Rössler, A.; Krebs, M.O.; Amminger, P.; Glenthøj, B.; Barrantes-Vidal, N.; van Os, J.; Rutten, B.P.F.; Bressan, R.A.; van der Gaag, M.; Yolken, R.; Hotopf, M.; Valmaggia, L.; Stone, J.; David, A.S.; Calem, M.; Tognin, S.; Modinos, G.; de Haan, L.; van der Gaag, M.; Velthorst, E.; Kraan, T.C.; van Dam, D.S.; Burger, N.; Nelson, B.; McGorry, P.; Pantelis, C.; Politis, A.; Goodall, J.; Borgwardt, S.; Ittig, S.; Studerus, E.; Smieskova, R.; Gadelha, A.; Brietzke, E.; Asevedo, G.; Asevedo, E.; Zugman, A.; Rosa, A.; Racioppi, A.; Monsonet, M.; Hinojosa-Marqués, L.; Kwapil, T.R.; Kazes, M.; Daban, C.; Bourgin, J.; Gay, O.; Mam-Lam-Fook, C.; Nordholm, D.; Randers, L.; Krakauer, K.; Glenthøj, L.; Nordentoft, M.; Gebhard, D.; Arnhold, J.; Klosterkötter, J.; Lasser, I.; Winklbaur, B.; Delespaul, P.A.; van Os, J.; McGuire, P. Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis. Mol. Psychiatry, 2021, 26(6), 2590-2604. doi: 10.1038/s41380-020-00899-w PMID: 33077853
  181. Smith, S.M.; Vale, W.W. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin. Neurosci., 2006, 8(4), 383-395. doi: 10.31887/DCNS.2006.8.4/ssmith PMID: 17290797
  182. McEwen, B.S.; Nasca, C.; Gray, J.D. Stress effects on neuronal structure: Hippocampus, amygdala, and prefrontal cortex. Neuropsychopharmacology, 2016, 41(1), 3-23. doi: 10.1038/npp.2015.171 PMID: 26076834
  183. Lupien, S.J.; Juster, R.P.; Raymond, C.; Marin, M.F. The effects of chronic stress on the human brain: From neurotoxicity, to vulnerability, to opportunity. Front. Neuroendocrinol., 2018, 49, 91-105. doi: 10.1016/j.yfrne.2018.02.001 PMID: 29421159
  184. Lupien, S.J.; McEwen, B.S.; Gunnar, M.R.; Heim, C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat. Rev. Neurosci., 2009, 10(6), 434-445. doi: 10.1038/nrn2639 PMID: 19401723
  185. Filiano, A.J.; Xu, Y.; Tustison, N.J.; Marsh, R.L.; Baker, W.; Smirnov, I.; Overall, C.C.; Gadani, S.P.; Turner, S.D.; Weng, Z.; Peerzade, S.N.; Chen, H.; Lee, K.S.; Scott, M.M.; Beenhakker, M.P.; Litvak, V.; Kipnis, J. Unexpected role of interferon-γ in regulating neuronal connectivity and social behaviour. Nature, 2016, 535(7612), 425-429. doi: 10.1038/nature18626 PMID: 27409813
  186. Howes, O.D.; McCutcheon, R. Inflammation and the neural diathesis-stress hypothesis of schizophrenia: A reconceptualization. Transl. Psychiatry, 2017, 7(2), e1024. doi: 10.1038/tp.2016.278 PMID: 28170004
  187. Reynolds, R.M.; Labad, J.; Buss, C.; Ghaemmaghami, P.; Räikkönen, K. Transmitting biological effects of stress in utero: Implications for mother and offspring. Psychoneuroendocrinology, 2013, 38(9), 1843-1849. doi: 10.1016/j.psyneuen.2013.05.018 PMID: 23810315
  188. Humphreys, K.L.; Camacho, M.C.; Roth, M.C.; Estes, E.C. Prenatal stress exposure and multimodal assessment of amygdala–medial prefrontal cortex connectivity in infants. Dev. Cogn. Neurosci., 2020, 46, 100877. doi: 10.1016/j.dcn.2020.100877 PMID: 33220629
  189. Sandman, C.A.; Curran, M.M.; Davis, E.P.; Glynn, L.M.; Head, K.; Baram, T.Z. Cortical thinning and neuropsychiatric outcomes in children exposed to prenatal adversity: A role for placental CRH? Am. J. Psychiatry, 2018, 175(5), 471-479. doi: 10.1176/appi.ajp.2017.16121433 PMID: 29495899
  190. Paquola, C.; Bennett, M.R.; Lagopoulos, J. Understanding heterogeneity in grey matter research of adults with childhood maltreatment—A meta-analysis and review. Neurosci. Biobehav. Rev., 2016, 69, 299-312. doi: 10.1016/j.neubiorev.2016.08.011 PMID: 27531235
  191. Heany, S.J.; Groenewold, N.A.; Uhlmann, A.; Dalvie, S.; Stein, D.J.; Brooks, S.J. The neural correlates of Childhood Trauma Questionnaire scores in adults: A meta-analysis and review of functional magnetic resonance imaging studies. Dev. Psychopathol., 2018, 30(4), 1475-1485. doi: 10.1017/S0954579417001717 PMID: 29224580
  192. Herringa, R.J.; Birn, R.M.; Ruttle, P.L.; Burghy, C.A.; Stodola, D.E.; Davidson, R.J.; Essex, M.J. Childhood maltreatment is associated with altered fear circuitry and increased internalizing symptoms by late adolescence. Proc. Natl. Acad. Sci., 2013, 110(47), 19119-19124. doi: 10.1073/pnas.1310766110 PMID: 24191026
  193. Rapado-Castro, M.; Whittle, S.; Pantelis, C.; Thompson, A.; Nelson, B.; Ganella, E.P.; Lin, A.; Reniers, R.L.E.P.; McGorry, P.D.; Yung, A.R.; Wood, S.J.; Bartholomeusz, C.F. Does cortical brain morphology act as a mediator between childhood trauma and transition to psychosis in young individuals at ultra-high risk? Schizophr. Res., 2020, 224, 116-125. doi: 10.1016/j.schres.2020.09.017 PMID: 33071072
  194. LoPilato, A.M.; Goines, K.; Addington, J.; Bearden, C.E.; Cadenhead, K.S.; Cannon, T.D.; Cornblatt, B.A.; Mathalon, D.H.; McGlashan, T.H.; Seidman, L.; Perkins, D.O.; Tsuang, M.T.; Woods, S.W.; Walker, E.F. Impact of childhood adversity on corticolimbic volumes in youth at clinical high-risk for psychosis. Schizophr. Res., 2019, 213, 48-55. doi: 10.1016/j.schres.2019.01.048 PMID: 30745068
  195. Allen, P.; Azis, M.; Modinos, G.; Bossong, M.G.; Bonoldi, I.; Samson, C.; Quinn, B.; Kempton, M.J.; Howes, O.D.; Stone, J.M.; Calem, M.; Perez, J.; Bhattacharayya, S.; Broome, M.R.; Grace, A.A.; Zelaya, F.; McGuire, P. Increased resting hippocampal and basal ganglia perfusion in people at ultra high risk for psychosis: Replication in a second cohort. Schizophr. Bull., 2018, 44(6), 1323-1331. doi: 10.1093/schbul/sbx169 PMID: 29294102
  196. Mondelli, V.; Pariante, C.M.; Navari, S.; Aas, M.; D’Albenzio, A.; Di Forti, M.; Handley, R.; Hepgul, N.; Marques, T.R.; Taylor, H.; Papadopoulos, A.S.; Aitchison, K.J.; Murray, R.M.; Dazzan, P. Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis. Schizophr. Res., 2010, 119(1-3), 75-78. doi: 10.1016/j.schres.2009.12.021 PMID: 20071148
  197. Mondelli, V.; Cattaneo, A.; Murri, M.B.; Di Forti, M.; Handley, R.; Hepgul, N.; Miorelli, A.; Navari, S.; Papadopoulos, A.S.; Aitchison, K.J.; Morgan, C.; Murray, R.M.; Dazzan, P.; Pariante, C.M. Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: A pathway to smaller hippocampal volume. J. Clin. Psychiatry, 2011, 72(12), 1677-1684. doi: 10.4088/JCP.10m06745 PMID: 21672499
  198. Pruessner, M.; Lepage, M.; Collins, D.L.; Pruessner, J.C.; Joober, R.; Malla, A.K. Reduced hippocampal volume and hypothalamus–pituitary–adrenal axis function in first episode psychosis: Evidence for sex differences. Neuroimage Clin., 2015, 7, 195-202. doi: 10.1016/j.nicl.2014.12.001 PMID: 25610781
  199. Pruessner, M.; Bechard-Evans, L.; Pira, S.; Joober, R.; Collins, D.L.; Pruessner, J.C.; Malla, A.K. Interplay of hippocampal volume and hypothalamus-pituitary-adrenal axis function as markers of stress vulnerability in men at ultra-high risk for psychosis. Psychol. Med., 2017, 47(3), 471-483. doi: 10.1017/S0033291716002658 PMID: 27774914
  200. Kose, M.; Pariante, C.M.; Dazzan, P.; Mondelli, V. The role of peripheral inflammation in clinical outcome and brain imaging abnormalities in psychosis: A systematic review. Front. Psychiatry, 2021, 12, 612471. doi: 10.3389/fpsyt.2021.612471 PMID: 33679475
  201. Quidé, Y.; Girshkin, L.; Watkeys, O.J.; Carr, V.J.; Green, M.J. The relationship between cortisol reactivity and emotional brain function is differently moderated by childhood trauma, in bipolar disorder, schizophrenia and healthy individuals. Eur. Arch. Psychiatry Clin. Neurosci., 2021, 271(6), 1089-1109. doi: 10.1007/s00406-020-01190-3 PMID: 32926285
  202. Cannon, T.D.; Chung, Y.; He, G.; Sun, D.; Jacobson, A.; van Erp, T.G.M.; McEwen, S.; Addington, J.; Bearden, C.E.; Cadenhead, K.; Cornblatt, B.; Mathalon, D.H.; McGlashan, T.; Perkins, D.; Jeffries, C.; Seidman, L.J.; Tsuang, M.; Walker, E.; Woods, S.W.; Heinssen, R. Progressive reduction in cortical thickness as psychosis develops: A multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biol. Psychiatry, 2015, 77(2), 147-157. doi: 10.1016/j.biopsych.2014.05.023 PMID: 25034946
  203. Mauri, M.; Sinforiani, E.; Bono, G.; Vignati, F.; Berselli, M.E.; Attanasio, R.; Nappi, G. Memory impairment in Cushing’s disease. Acta Neurol. Scand., 1993, 87(1), 52-55. doi: 10.1111/j.1600-0404.1993.tb04075.x PMID: 8424312
  204. Resmini, E.; Santos, A.; Gómez-Anson, B.; Vives, Y.; Pires, P.; Crespo, I.; Portella, M.J.; de Juan-Delago, M.; Barahona, M.J.; Webb, S.M. Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushing’s syndrome. J. Clin. Endocrinol. Metab., 2012, 97(2), 663-671. doi: 10.1210/jc.2011-2231 PMID: 22162471
  205. Bourdeau, I.; Bard, C.; Noël, B.; Leclerc, I.; Cordeau, M.P.; Bélair, M.; Lesage, J.; Lafontaine, L.; Lacroix, A. Loss of brain volume in endogenous Cushing’s syndrome and its reversibility after correction of hypercortisolism. J. Clin. Endocrinol. Metab., 2002, 87(5), 1949-1954. PMID: 11994323
  206. Starkman, M.N. Neuropsychiatric findings in Cushing syndrome and exogenous glucocorticoid administration. Endocrinol. Metab. Clin. North Am., 2013, 42(3), 477-488. doi: 10.1016/j.ecl.2013.05.010 PMID: 24011881
  207. Resmini, E.; Santos, A.; Webb, S.M. Cortisol excess and the brain. Front. Horm. Res., 2016, 46, 74-86. doi: 10.1159/000443868 PMID: 27210466
  208. Lupien, S.J.; Schwartz, G.; Ng, Y.K.; Fiocco, A.; Wan, N.; Pruessner, J.C.; Meaney, M.J.; Nair, N.P. The douglas hospital longitudinal study of normal and pathological aging: Summary of findings. J. Psychiatry Neurosci., 2005, 30(5), 328-334. PMID: 16151537
  209. Zheng, B.; Tal, R.; Yang, Z.; Middleton, L.; Udeh-Momoh, C. Cortisol hypersecretion and the risk of Alzheimer’s disease: A systematic review and meta-analysis. Ageing Res. Rev., 2020, 64, 101171. doi: 10.1016/j.arr.2020.101171 PMID: 32971258
  210. Green, M.F.; Horan, W.P.; Lee, J. Nonsocial and social cognition in schizophrenia: Current evidence and future directions. World Psychiatry, 2019, 18(2), 146-161. doi: 10.1002/wps.20624 PMID: 31059632
  211. Fusar-Poli, P.; Deste, G.; Smieskova, R.; Barlati, S.; Yung, A.R.; Howes, O.; Stieglitz, R.D.; Vita, A.; McGuire, P.; Borgwardt, S. Cognitive functioning in prodromal psychosis: a meta-analysis. Arch. Gen. Psychiatry, 2012, 69(6), 562-571. doi: 10.1001/archgenpsychiatry.2011.1592 PMID: 22664547
  212. Millman, Z.B.; Roemer, C.; Vargas, T.; Schiffman, J.; Mittal, V.A.; Gold, J.M. Neuropsychological performance among individuals at clinical high-risk for psychosis vs putatively low-risk peers with other psychopathology: A systematic review and meta-analysis. Schizophr. Bull., 2022, 48(5), 999-1010. doi: 10.1093/schbul/sbac031 PMID: 35333372
  213. Havelka, D.; Prikrylova-Kucerova, H.; Prikryl, R.; Ceskova, E. Cognitive impairment and cortisol levels in first-episode schizophrenia patients. Stress, 2016, 19(4), 383-389. doi: 10.1080/10253890.2016.1193146 PMID: 27320489
  214. Aas, M.; Pizzagalli, D.A.; Laskemoen, J.F.; Reponen, E.J.; Ueland, T.; Melle, I.; Agartz, I.; Steen, N.E.; Andreassen, O.A. Elevated hair cortisol is associated with childhood maltreatment and cognitive impairment in schizophrenia and in bipolar disorders. Schizophr. Res., 2019, 213, 65-71. doi: 10.1016/j.schres.2019.01.011 PMID: 30660575
  215. Aas, M.; Dazzan, P.; Fisher, H.L.; Morgan, C.; Morgan, K.; Reichenberg, A.; Zanelli, J.; Fearon, P.; Jones, P.B.; Murray, R.M.; Pariante, C.M. Childhood trauma and cognitive function in first-episode affective and non-affective psychosis. Schizophr. Res., 2011, 129(1), 12-19. doi: 10.1016/j.schres.2011.03.017 PMID: 21601792
  216. Cullen, A.E.; Zunszain, P.A.; Dickson, H.; Roberts, R.E.; Fisher, H.L.; Pariante, C.M.; Laurens, K.R. Cortisol awakening response and diurnal cortisol among children at elevated risk for schizophrenia: Relationship to psychosocial stress and cognition. Psychoneuroendocrinology, 2014, 46(100), 1-13. doi: 10.1016/j.psyneuen.2014.03.010 PMID: 24882153
  217. Labad, J.; Gutiérrez-Zotes, A.; Creus, M.; Montalvo, I.; Cabezas, Á.; Solé, M.; Ortega, L.; Algora, M.J.; Sánchez-Gistau, V.; Vilella, E. Hypothalamic-pituitary-adrenal axis measures and cognitive abilities in early psychosis: Are there sex differences? Psychoneuroendocrinology, 2016, 72, 54-62. doi: 10.1016/j.psyneuen.2016.06.006 PMID: 27344379
  218. Khandaker, G.M.; Cousins, L.; Deakin, J.; Lennox, B.R.; Yolken, R.; Jones, P.B. Inflammation and immunity in schizophrenia: Implications for pathophysiology and treatment. Lancet Psychiatry, 2015, 2(3), 258-270. doi: 10.1016/S2215-0366(14)00122-9 PMID: 26359903
  219. Morrens, M.; Overloop, C.; Coppens, V.; Loots, E.; Van Den Noortgate, M.; Vandenameele, S.; Leboyer, M.; De Picker, L. The relationship between immune and cognitive dysfunction in mood and psychotic disorder: A systematic review and a meta-analysis. Mol. Psychiatry, 2022, 27(8), 3237-3246. doi: 10.1038/s41380-022-01582-y PMID: 35484245
  220. Patlola, S.R.; Donohoe, G.; McKernan, D.P. The relationship between inflammatory biomarkers and cognitive dysfunction in patients with schizophrenia: A systematic review and meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2023, 121, 110668. doi: 10.1016/j.pnpbp.2022.110668 PMID: 36283512
  221. Thursby, E.; Juge, N. Introduction to the human gut microbiota. Biochem. J., 2017, 474(11), 1823-1836. doi: 10.1042/BCJ20160510 PMID: 28512250
  222. Qin, J.; Li, R.; Raes, J.; Arumugam, M.; Burgdorf, K.S.; Manichanh, C.; Nielsen, T.; Pons, N.; Levenez, F.; Yamada, T.; Mende, D.R.; Li, J.; Xu, J.; Li, S.; Li, D.; Cao, J.; Wang, B.; Liang, H.; Zheng, H.; Xie, Y.; Tap, J.; Lepage, P.; Bertalan, M.; Batto, J.M.; Hansen, T.; Le Paslier, D.; Linneberg, A.; Nielsen, H.B.; Pelletier, E.; Renault, P.; Sicheritz-Ponten, T.; Turner, K.; Zhu, H.; Yu, C.; Li, S.; Jian, M.; Zhou, Y.; Li, Y.; Zhang, X.; Li, S.; Qin, N.; Yang, H.; Wang, J.; Brunak, S.; Doré, J.; Guarner, F.; Kristiansen, K.; Pedersen, O.; Parkhill, J.; Weissenbach, J.; Bork, P.; Ehrlich, S.D.; Wang, J.; Wang, J. A human gut microbial gene catalogue established by metagenomic sequencing. Nature, 2010, 464(7285), 59-65. doi: 10.1038/nature08821 PMID: 20203603
  223. Sender, R.; Fuchs, S.; Milo, R. Are we really vastly outnumbered? revisiting the ratio of bacterial to host cells in humans. Cell, 2016, 164(3), 337-340. doi: 10.1016/j.cell.2016.01.013 PMID: 26824647
  224. Dinan, T.G.; Cryan, J.F. Brain-gut-microbiota axis and mental health. Psychosom. Med., 2017, 79(8), 920-926. doi: 10.1097/PSY.0000000000000519 PMID: 28806201
  225. de Weerth, C. Do bacteria shape our development? crosstalk between intestinal microbiota and HPA axis. Neurosci. Biobehav. Rev., 2017, 83, 458-471. doi: 10.1016/j.neubiorev.2017.09.016 PMID: 28918360
  226. Hantsoo, L.; Zemel, B.S. Stress gets into the belly: Early life stress and the gut microbiome. Behav. Brain Res., 2021, 414, 113474. doi: 10.1016/j.bbr.2021.113474 PMID: 34280457
  227. Kelly, J.R.; Minuto, C.; Cryan, J.F.; Clarke, G.; Dinan, T.G. The role of the gut microbiome in the development of schizophrenia. Schizophr. Res., 2021, 234, 4-23. doi: 10.1016/j.schres.2020.02.010 PMID: 32336581
  228. Zijlmans, M.A.C.; Korpela, K.; Riksen-Walraven, J.M.; de Vos, W.M.; de Weerth, C. Maternal prenatal stress is associated with the infant intestinal microbiota. Psychoneuroendocrinology, 2015, 53, 233-245. doi: 10.1016/j.psyneuen.2015.01.006 PMID: 25638481
  229. Jašarević, E.; Howerton, C.L.; Howard, C.D.; Bale, T.L. Alterations in the vaginal microbiome by maternal stress are associated with metabolic reprogramming of the offspring gut and brain. Endocrinology, 2015, 156(9), 3265-3276. doi: 10.1210/en.2015-1177 PMID: 26079804
  230. Flannery, J.E.; Stagaman, K.; Burns, A.R.; Hickey, R.J.; Roos, L.E.; Giuliano, R.J.; Fisher, P.A.; Sharpton, T.J. Gut feelings begin in childhood: The gut metagenome correlates with early environment, caregiving, and behavior. MBio, 2020, 11(1), e02780-e19. doi: 10.1128/mBio.02780-19 PMID: 31964729
  231. Reid, B.M.; Horne, R.; Donzella, B.; Szamosi, J.C.; Coe, C.L.; Foster, J.A.; Gunnar, M.R. Microbiota‐immune alterations in adolescents following early life adversity: A proof of concept study. Dev. Psychobiol., 2021, 63(5), 851-863. doi: 10.1002/dev.22061 PMID: 33249563
  232. Bailey, M.T.; Coe, C.L. Maternal separation disrupts the integrity of the intestinal microflora in infant rhesus monkeys. Dev. Psychobiol., 1999, 35(2), 146-155. doi: 10.1002/(SICI)1098-2302(199909)35:23.0.CO;2-G PMID: 10461128
  233. O’Mahony, S.M.; Marchesi, J.R.; Scully, P.; Codling, C.; Ceolho, A.M.; Quigley, E.M.M.; Cryan, J.F.; Dinan, T.G. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol. Psychiatry, 2009, 65(3), 263-267. doi: 10.1016/j.biopsych.2008.06.026 PMID: 18723164
  234. Vangay, P.; Johnson, A.J.; Ward, T.L.; Al-Ghalith, G.A.; Shields-Cutler, R.R.; Hillmann, B.M.; Lucas, S.K.; Beura, L.K.; Thompson, E.A.; Till, L.M.; Batres, R.; Paw, B.; Pergament, S.L.; Saenyakul, P.; Xiong, M.; Kim, A.D.; Kim, G.; Masopust, D.; Martens, E.C.; Angkurawaranon, C.; McGready, R.; Kashyap, P.C.; Culhane-Pera, K.A.; Knights, D. US immigration westernizes the human gut microbiome. Cell, 2018, 175(4), 962-972.e10. doi: 10.1016/j.cell.2018.10.029 PMID: 30388453
  235. Mancabelli, L.; Milani, C.; Lugli, G.A.; Turroni, F.; Ferrario, C.; van Sinderen, D.; Ventura, M. Meta-analysis of the human gut microbiome from urbanized and pre-agricultural populations. Environ. Microbiol., 2017, 19(4), 1379-1390. doi: 10.1111/1462-2920.13692 PMID: 28198087
  236. Luczynski, P.; McVey Neufeld, K.A.; Oriach, C.S.; Clarke, G.; Dinan, T.G.; Cryan, J.F. Growing up in a bubble: Using germ-free animals to assess the influence of the gut microbiota on brain and behavior. Int. J. Neuropsychopharmacol., 2016, 19(8), pyw020. doi: 10.1093/ijnp/pyw020 PMID: 26912607
  237. Degroote, S.; Hunting, D.J.; Baccarelli, A.A.; Takser, L. Maternal gut and fetal brain connection: Increased anxiety and reduced social interactions in wistar rat offspring following peri-conceptional antibiotic exposure. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2016, 71, 76-82. doi: 10.1016/j.pnpbp.2016.06.010 PMID: 27346743
  238. Leclercq, S.; Mian, F.M.; Stanisz, A.M.; Bindels, L.B.; Cambier, E.; Ben-Amram, H.; Koren, O.; Forsythe, P.; Bienenstock, J. Low-dose penicillin in early life induces long-term changes in murine gut microbiota, brain cytokines and behavior. Nat. Commun., 2017, 8(1), 15062. doi: 10.1038/ncomms15062 PMID: 28375200
  239. Lieberman, J.A.; Girgis, R.R.; Brucato, G.; Moore, H.; Provenzano, F.; Kegeles, L.; Javitt, D.; Kantrowitz, J.; Wall, M.M.; Corcoran, C.M.; Schobel, S.A.; Small, S.A. Hippocampal dysfunction in the pathophysiology of schizophrenia: A selective review and hypothesis for early detection and intervention. Mol. Psychiatry, 2018, 23(8), 1764-1772. doi: 10.1038/mp.2017.249 PMID: 29311665
  240. Rea, K.; Dinan, T.G.; Cryan, J.F. The microbiome: A key regulator of stress and neuroinflammation. Neurobiol. Stress, 2016, 4, 23-33. doi: 10.1016/j.ynstr.2016.03.001 PMID: 27981187
  241. Schmidt, K.; Cowen, P.J.; Harmer, C.J.; Tzortzis, G.; Errington, S.; Burnet, P.W.J. Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology, 2015, 232(10), 1793-1801. doi: 10.1007/s00213-014-3810-0 PMID: 25449699
  242. Messaoudi, M.; Violle, N.; Bisson, J.F.; Desor, D.; Javelot, H.; Rougeot, C. Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes, 2011, 2(4), 256-261. doi: 10.4161/gmic.2.4.16108 PMID: 21983070
  243. de Weerth, C.; Zijl, R.H.; Buitelaar, J.K. Development of cortisol circadian rhythm in infancy. Early Hum. Dev., 2003, 73(1-2), 39-52. doi: 10.1016/S0378-3782(03)00074-4 PMID: 12932892
  244. de Weerth, C.; Fuentes, S.; Puylaert, P.; de Vos, W.M. Intestinal microbiota of infants with colic: development and specific signatures. Pediatrics, 2013, 131(2), e550-e558. doi: 10.1542/peds.2012-1449 PMID: 23319531
  245. Chu, D.M.; Ma, J.; Prince, A.L.; Antony, K.M.; Seferovic, M.D.; Aagaard, K.M. Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nat. Med., 2017, 23(3), 314-326. doi: 10.1038/nm.4272 PMID: 28112736
  246. Underwood, M.A.; German, J.B.; Lebrilla, C.B.; Mills, D.A. Bifidobacterium longum subspecies infantis: Champion colonizer of the infant gut. Pediatr. Res., 2015, 77(1-2), 229-235. doi: 10.1038/pr.2014.156 PMID: 25303277
  247. Dinan, T.G.; Stilling, R.M.; Stanton, C.; Cryan, J.F. Collective unconscious: How gut microbes shape human behavior. J. Psychiatr. Res., 2015, 63, 1-9. doi: 10.1016/j.jpsychires.2015.02.021 PMID: 25772005
  248. Dinan, T.G.; Kennedy, P.J.; Morais, L.H.; Murphy, A.; Long-Smith, C.M.; Moloney, G.M.; Bastiaanssen, T.F.S.; Allen, A.P.; Collery, A.; Mullins, D.; Cusack, A.M.; Berding, K.; O’Toole, P.W.; Clarke, G.; Stanton, C.; Cryan, J.F. Altered stress responses in adults born by Caesarean section. Neurobiol. Stress, 2022, 16, 100425. doi: 10.1016/j.ynstr.2021.100425 PMID: 35024387
  249. Dalla Costa, G.; Romeo, M.; Esposito, F.; Sangalli, F.; Colombo, B.; Radaelli, M.; Moiola, L.; Comi, G.; Martinelli, V. Caesarean section and infant formula feeding are associated with an earlier age of onset of multiple sclerosis. Mult. Scler. Relat. Disord., 2019, 33, 75-77. doi: 10.1016/j.msard.2019.05.010 PMID: 31158806
  250. O’Neill, S.M.; Curran, E.A.; Dalman, C.; Kenny, L.C.; Kearney, P.M.; Clarke, G.; Cryan, J.F.; Dinan, T.G.; Khashan, A.S. Birth by caesarean section and the risk of adult psychosis: A population-based cohort study. Schizophr. Bull., 2016, 42(3), 633-641. doi: 10.1093/schbul/sbv152 PMID: 26615187
  251. Safadi, J.M.; Quinton, A.M.G.; Lennox, B.R.; Burnet, P.W.J.; Minichino, A. Gut dysbiosis in severe mental illness and chronic fatigue: a novel trans-diagnostic construct? A systematic review and meta-analysis. Mol. Psychiatry, 2022, 27(1), 141-153. doi: 10.1038/s41380-021-01032-1 PMID: 33558650
  252. Nikolova, V.L.; Smith, M.R.B.; Hall, L.J.; Cleare, A.J.; Stone, J.M.; Young, A.H. Perturbations in gut microbiota composition in psychiatric disorders. JAMA Psychiatry, 2021, 78(12), 1343-1354. doi: 10.1001/jamapsychiatry.2021.2573 PMID: 34524405
  253. Zhu, F.; Guo, R.; Wang, W.; Ju, Y.; Wang, Q.; Ma, Q.; Sun, Q.; Fan, Y.; Xie, Y.; Yang, Z.; Jie, Z.; Zhao, B.; Xiao, L.; Yang, L.; Zhang, T.; Liu, B.; Guo, L.; He, X.; Chen, Y.; Chen, C.; Gao, C.; Xu, X.; Yang, H.; Wang, J.; Dang, Y.; Madsen, L.; Brix, S.; Kristiansen, K.; Jia, H.; Ma, X. Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice. Mol. Psychiatry, 2020, 25(11), 2905-2918. doi: 10.1038/s41380-019-0475-4 PMID: 31391545
  254. Zheng, P.; Zeng, B.; Liu, M.; Chen, J.; Pan, J.; Han, Y.; Liu, Y.; Cheng, K.; Zhou, C.; Wang, H.; Zhou, X.; Gui, S.; Perry, S.W.; Wong, M.L.; Licinio, J.; Wei, H.; Xie, P. The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice. Sci. Adv., 2019, 5(2), eaau8317. doi: 10.1126/sciadv.aau8317 PMID: 30775438
  255. Schwarz, E.; Maukonen, J.; Hyytiäinen, T.; Kieseppä, T.; Orešič, M.; Sabunciyan, S.; Mantere, O.; Saarela, M.; Yolken, R.; Suvisaari, J. Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response. Schizophr. Res., 2018, 192, 398-403. doi: 10.1016/j.schres.2017.04.017 PMID: 28442250
  256. He, Y.; Kosciolek, T.; Tang, J.; Zhou, Y.; Li, Z.; Ma, X.; Zhu, Q.; Yuan, N.; Yuan, L.; Li, C.; Jin, K.; Knight, R.; Tsuang, M.T.; Chen, X. Gut microbiome and magnetic resonance spectroscopy study of subjects at ultra-high risk for psychosis may support the membrane hypothesis. Eur. Psychiatry, 2018, 53, 37-45. doi: 10.1016/j.eurpsy.2018.05.011 PMID: 29870894
  257. Yuan, X.; Zhang, P.; Wang, Y.; Liu, Y.; Li, X.; Kumar, B.U.; Hei, G.; Lv, L.; Huang, X.F.; Fan, X.; Song, X. Changes in metabolism and microbiota after 24-week risperidone treatment in drug naïve, normal weight patients with first episode schizophrenia. Schizophr. Res., 2018, 201, 299-306. doi: 10.1016/j.schres.2018.05.017 PMID: 29859859
  258. Zheng, D.; Liwinski, T.; Elinav, E. Interaction between microbiota and immunity in health and disease. Cell Res., 2020, 30(6), 492-506. doi: 10.1038/s41422-020-0332-7 PMID: 32433595
  259. Petta, I.; Fraussen, J.; Somers, V.; Kleinewietfeld, M. Interrelation of diet, gut microbiome, and autoantibody production. Front. Immunol., 2018, 9, 439. doi: 10.3389/fimmu.2018.00439 PMID: 29559977
  260. Kim, M.; Kim, C.H. Regulation of humoral immunity by gut microbial products. Gut Microbes, 2017, 8(4), 392-399. doi: 10.1080/19490976.2017.1299311 PMID: 28332901
  261. Kennedy, P.J.; Cryan, J.F.; Dinan, T.G.; Clarke, G. Kynurenine pathway metabolism and the microbiota-gut-brain axis. Neuropharmacology, 2017, 112((Pt B)), 399-412. doi: 10.1016/j.neuropharm.2016.07.002
  262. Dalile, B.; Van Oudenhove, L.; Vervliet, B.; Verbeke, K. The role of short-chain fatty acids in microbiota–gut–brain communication. Nat. Rev. Gastroenterol. Hepatol., 2019, 16(8), 461-478. doi: 10.1038/s41575-019-0157-3 PMID: 31123355
  263. Minichino, A.; Jackson, M.A.; Francesconi, M.; Steves, C.J.; Menni, C.; Burnet, P.W.J.; Lennox, B.R. Endocannabinoid system mediates the association between gut-microbial diversity and anhedonia/amotivation in a general population cohort. Mol. Psychiatry, 2021, 26(11), 6269-6276. doi: 10.1038/s41380-021-01147-5 PMID: 34002020
  264. Sudo, N. Microbiome, HPA axis and production of endocrine hormones in the gut. Adv. Exp. Med. Biol., 2014, 817, 177-194. doi: 10.1007/978-1-4939-0897-4_8 PMID: 24997034
  265. Mondelli, V.; Dazzan, P.; Hepgul, N.; Di Forti, M.; Aas, M.; D’Albenzio, A.; Di Nicola, M.; Fisher, H.; Handley, R.; Marques, T.R.; Morgan, C.; Navari, S.; Taylor, H.; Papadopoulos, A.; Aitchison, K.J.; Murray, R.M.; Pariante, C.M. Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: The role of stress and of antipsychotic treatment. Schizophr. Res., 2010, 116(2-3), 234-242. doi: 10.1016/j.schres.2009.08.013 PMID: 19751968
  266. Cohrs, S.; Röher, C.; Jordan, W.; Meier, A.; Huether, G.; Wuttke, W.; Rüther, E.; Rodenbeck, A. The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects. Psychopharmacology, 2006, 185(1), 11-18. doi: 10.1007/s00213-005-0279-x PMID: 16432682
  267. Zhang, X.Y.; Zhou, D.F.; Cao, L.Y.; Wu, G.Y.; Shen, Y.C. Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics. Neuropsychopharmacology, 2005, 30(8), 1532-1538. doi: 10.1038/sj.npp.1300756 PMID: 15886721
  268. Capuzzi, E.; Bartoli, F.; Crocamo, C.; Clerici, M.; Carrà, G. Acute variations of cytokine levels after antipsychotic treatment in drug-naïve subjects with a first-episode psychosis: A meta-analysis. Neurosci. Biobehav. Rev., 2017, 77, 122-128. doi: 10.1016/j.neubiorev.2017.03.003 PMID: 28285148
  269. Seeman, M.V. The gut microbiome and antipsychotic treatment response. Behav. Brain Res., 2021, 396, 112886. doi: 10.1016/j.bbr.2020.112886 PMID: 32890599
  270. Maier, L.; Pruteanu, M.; Kuhn, M.; Zeller, G.; Telzerow, A.; Anderson, E.E.; Brochado, A.R.; Fernandez, K.C.; Dose, H.; Mori, H.; Patil, K.R.; Bork, P.; Typas, A. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature, 2018, 555(7698), 623-628. doi: 10.1038/nature25979 PMID: 29555994
  271. Price, L.H.; Malison, R.T.; McDougle, C.J.; Pelton, G.H. Antiglucocorticoids as treatments for depression. CNS Drugs, 1996, 5(5), 311-320. doi: 10.2165/00023210-199605050-00001 PMID: 26071044
  272. Garner, B.; Phillips, L.J.; Bendall, S.; Hetrick, S.E. Antiglucocorticoid and related treatments for psychosis. Cochrane Database Syst. Rev., 2016, 1(1), CD006995. PMID: 26725721
  273. DeBattista, C.; Belanoff, J.; Glass, S.; Khan, A.; Horne, R.L.; Blasey, C.; Carpenter, L.L.; Alva, G. Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression. Biol. Psychiatry, 2006, 60(12), 1343-1349. doi: 10.1016/j.biopsych.2006.05.034 PMID: 16889757
  274. Lombardo, G.; Enache, D.; Gianotti, L.; Schatzberg, A.F.; Young, A.H.; Pariante, C.M.; Mondelli, V. Baseline cortisol and the efficacy of antiglucocorticoid treatment in mood disorders: A meta-analysis. Psychoneuroendocrinology, 2019, 110, 104420. doi: 10.1016/j.psyneuen.2019.104420 PMID: 31499391
  275. Nitta, M.; Kishimoto, T.; Müller, N.; Weiser, M.; Davidson, M.; Kane, J.M.; Correll, C.U. Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: A meta-analytic investigation of randomized controlled trials. Schizophr. Bull., 2013, 39(6), 1230-1241. doi: 10.1093/schbul/sbt070 PMID: 23720576
  276. Jeppesen, R.; Christensen, R.H.B.; Pedersen, E.M.J.; Nordentoft, M.; Hjorthøj, C.; Köhler-Forsberg, O.; Benros, M.E. Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders – A comprehensive systematic review and meta-analysis. Brain Behav. Immun., 2020, 90, 364-380. doi: 10.1016/j.bbi.2020.08.028 PMID: 32890697
  277. Girgis, R.R.; Ciarleglio, A.; Choo, T.; Haynes, G.; Bathon, J.M.; Cremers, S.; Kantrowitz, J.T.; Lieberman, J.A.; Brown, A.S. A randomized, double-blind, placebo-controlled clinical trial of tocilizumab, an interleukin-6 receptor antibody, for residual symptoms in schizophrenia. Neuropsychopharmacology, 2018, 43(6), 1317-1323. doi: 10.1038/npp.2017.258 PMID: 29090685
  278. Miller, B.J.; Goldsmith, D.R. Towards an immunophenotype of schizophrenia: Progress, potential mechanisms, and future directions. Neuropsychopharmacology, 2017, 42(1), 299-317. doi: 10.1038/npp.2016.211 PMID: 27654215
  279. Lee, Y.; Subramaniapillai, M.; Brietzke, E.; Mansur, R.B.; Ho, R.C.; Yim, S.J.; McIntyre, R.S. Anti-cytokine agents for anhedonia: Targeting inflammation and the immune system to treat dimensional disturbances in depression. Ther. Adv. Psychopharmacol., 2018, 8(12), 337-348. doi: 10.1177/2045125318791944 PMID: 30524702
  280. Berding, K.; Cryan, J.F. Microbiota-targeted interventions for mental health. Curr. Opin. Psychiatry, 2022, 35(1), 3-9. doi: 10.1097/YCO.0000000000000758 PMID: 34750307
  281. Mörkl, S.; Butler, M.I.; Holl, A.; Cryan, J.F.; Dinan, T.G. Probiotics and the microbiota-gut-brain axis: Focus on psychiatry. Curr. Nutr. Rep., 2020, 9(3), 171-182. doi: 10.1007/s13668-020-00313-5 PMID: 32406013
  282. Minichino, A.; Brondino, N.; Solmi, M.; Del Giovane, C.; Fusar-Poli, P.; Burnet, P.; Cipriani, A.; Lennox, B.R. The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies. Schizophr. Res., 2021, 234, 58-70. doi: 10.1016/j.schres.2020.02.012 PMID: 32295752
  283. Sepede, G.; Spano, M.C.; Lorusso, M.; De Berardis, D.; Salerno, R.M.; Di Giannantonio, M.; Gambi, F. Sustained attention in psychosis: Neuroimaging findings. World J. Radiol., 2014, 6(6), 261-273. doi: 10.4329/wjr.v6.i6.261 PMID: 24976929
  284. Mazza, M.; Caroppo, E.; De Berardis, D.; Marano, G.; Avallone, C.; Kotzalidis, G.D.; Janiri, D.; Moccia, L.; Simonetti, A.; Conte, E.; Martinotti, G.; Janiri, L.; Sani, G. Psychosis in women: Time for personalized treatment. J. Pers. Med., 2021, 11(12), 1279. doi: 10.3390/jpm11121279 PMID: 34945748
  285. Oliver, D.; Spada, G.; Englund, A.; Chesney, E.; Radua, J.; Reichenberg, A.; Uher, R.; McGuire, P.; Fusar-Poli, P. Real-world digital implementation of the Psychosis Polyrisk Score (PPS): A pilot feasibility study. Schizophr. Res., 2020, 226, 176-183. doi: 10.1016/j.schres.2020.04.015 PMID: 32340785
  286. Oliver, D.; Radua, J.; Reichenberg, A.; Uher, R.; Fusar-Poli, P. Psychosis Polyrisk Score (PPS) for the detection of individuals at-risk and the prediction of their outcomes. Front. Psychiatry, 2019, 10, 174. doi: 10.3389/fpsyt.2019.00174 PMID: 31057431
  287. Baldwin, H.; Loebel-Davidsohn, L.; Oliver, D.; Salazar de Pablo, G.; Stahl, D.; Riper, H.; Fusar-Poli, P. Real-world implementation of precision psychiatry: A systematic review of barriers and facilitators. Brain Sci., 2022, 12(7), 934. doi: 10.3390/brainsci12070934 PMID: 35884740
  288. Salazar de Pablo, G.; Studerus, E.; Vaquerizo-Serrano, J.; Irving, J.; Catalan, A.; Oliver, D.; Baldwin, H.; Danese, A.; Fazel, S.; Steyerberg, E.W.; Stahl, D.; Fusar-Poli, P. Implementing precision psychiatry: A systematic review of individualized prediction models for clinical practice. Schizophr. Bull., 2021, 47(2), 284-297. doi: 10.1093/schbul/sbaa120 PMID: 32914178
  289. Meehan, A.J.; Lewis, S.J.; Fazel, S.; Fusar-Poli, P.; Steyerberg, E.W.; Stahl, D.; Danese, A. Clinical prediction models in psychiatry: A systematic review of two decades of progress and challenges. Mol. Psychiatry, 2022, 27(6), 2700-2708. doi: 10.1038/s41380-022-01528-4 PMID: 35365801
  290. Pries, L.K.; Lage-Castellanos, A.; Delespaul, P.; Kenis, G.; Luykx, J.J.; Lin, B.D.; Richards, A.L.; Akdede, B.; Binbay, T.; Altinyazar, V.; Yalinçetin, B.; Gümüş-Akay, G.; Cihan, B.; Soygür, H.; Ulaş, H.; Cankurtaran, E.Ş.; Kaymak, S.U.; Mihaljevic, M.M.; Petrovic, S.A.; Mirjanic, T.; Bernardo, M.; Cabrera, B.; Bobes, J.; Saiz, P.A.; García-Portilla, M.P.; Sanjuan, J.; Aguilar, E.J.; Santos, J.L.; Jiménez-López, E.; Arrojo, M.; Carracedo, A.; López, G.; González-Peñas, J.; Parellada, M.; Maric, N.P.; Atbaşoğlu, C.; Ucok, A.; Alptekin, K.; Saka, M.C.; Alizadeh, B.Z.; van Amelsvoort, T.; Bruggeman, R.; Cahn, W.; de Haan, L.; Luykx, J.J.; van Winkel, R.; Rutten, B.P.F.; van Os, J.; Arango, C.; O’Donovan, M.; Rutten, B.P.F.; van Os, J.; Guloksuz, S. Estimating exposome score for schizophrenia using predictive modeling approach in two independent samples: The results from the EUGEI study. Schizophr. Bull., 2019, 45(5), 960-965. doi: 10.1093/schbul/sbz054 PMID: 31508804
  291. Jeon, E.J.; Kang, S.H.; Piao, Y.H.; Kim, S.W.; Kim, J.J.; Lee, B.J.; Yu, J.C.; Lee, K.Y.; Won, S.H.; Lee, S.H.; Kim, S.H.; Kim, E.T.; Kim, C.T.; Oliver, D.; Fusar-Poli, P.; Rami, F.Z.; Chung, Y.C. Development of the korea-polyenvironmental risk score for psychosis. Psychiatry Investig., 2022, 19(3), 197-206. doi: 10.30773/pi.2021.0328 PMID: 35196829
  292. Oliver, D. The importance of external validation to advance precision psychiatry. Lancet Reg. Health Eur., 2022, 22, 100498. doi: 10.1016/j.lanepe.2022.100498 PMID: 36061494

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bentham Science Publishers, 2024